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This study tested the hypotheses that 1) 28h head-down bed-rest (HDBR) would 
result in significant hypovolemia and cardiovascular deconditioning, and that 2) 
NASA‟s fluid loading protocol (ingestion of 15 ml/kg water with a 1g NaCl for 
every 125ml of water consumed) would restore normovolemia and prevent 
cardiovascular deconditioning resulting from 28h HDBR. Nine healthy men 
were tested in 5 testing scenarios, with a progressive lower body negative 
pressure (LBNP) protocol performed before and after each scenario to measure 
the subjects‟ cardiovascular responses to orthostasis. Subjects were tested in 
two 28h HDBR conditions, without fluid loading (NFL) and with fluid loading 
(FL), as well as in three 4-hour control conditions to isolate the effects of 
circadian rhythm, HDBR, and fluid loading.   
After 28h NFL HDBR, plasma volume was reduced by 8%. There were 
no symptoms of syncope during orthostatic testing following 28h NFL HDBR, 
however cardiovascular deconditioning was apparent as there were significant 
increases in heart rate, reductions in central venous pressure, and reductions in 
portal vein diameter during LBNP testing. There were no changes in stroke 
volume, cardiac output, systemic vasoconstriction, cardiac measures, and 
arterial and cardiopulmonary baroreflex responses, and no evidence of 
splanchnic or venous pooling.  
This study also found that NASA‟s fluid loading protocol was 
ineffective at restoring normovolemia after 28h HDBR, as there were no 
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differences in plasma volume between 28h FL HDBR post and 28h NFL HDBR 
post tests (p=0.22). Cardiovascular deconditioning was not prevented by fluid 
loading as the heart rate response remained elevated and central venous 
pressure remained reduced after 28h FL HDBR. In addition, four of the nine 
subjects experienced nausea during administration of the fluid loading protocol 
prescription and two subjects vomited, further evidence that NASA‟s fluid 
loading protocol is not effective at preventing orthostatic hypotension. 
Investigation of control models verified that deconditioning was the 
result of HDBR. It was also concluded that circadian rhythm did not affect the 
measured cardiovascular responses and the fluid loading protocol was 
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1 INTRODUCTION 
A common cardiovascular response experienced by astronauts returning from 
spaceflight is orthostatic hypotension. The term orthostatic hypotension 
describes the fall in blood pressure that arises due to postural stress and can lead 
to presyncope and syncope. Presyncope is generally defined as a fall in systolic 
blood pressure to 70 mmHg and may be accompanied by dizziness, narrowing 
of vision and fainting. The condition is common in young women and the 
elderly on Earth; however the susceptibility of healthy astronauts to orthostatic 
hypotension and presyncope is exacerbated upon return to spaceflight. Buckey 
and colleagues reported that up to 64% of astronauts experience orthostatic 
hypotension following exposure to microgravity (Buckey et al. 1996). Meck 
and colleagues found that short duration (2 week) flights resulted in 20% of 
astronauts experiencing presyncope, whereas the rate rose to 83% following 
long duration (129-190 day) spaceflight (Meck et al. 2001). 
Many studies have worked to identify the mechanisms that lead to 
orthostatic hypotension following exposure to microgravity in an otherwise 
healthy population of astronauts.  Hypovolemia is suspected to play an 
important role in cardiovascular deconditioning following exposure to 
microgravity. This may lead to increased peripheral resistance, reduction in 
vasoconstrictor reserve, attenuated arterial baroreflex, and changes in cardiac 
function.  Other effects of bed-rest, such as compliance and changes in systemic 
blood distribution, are not thought to be directly linked to hypovolemia but 
result from bed-rest deconditioning.  Together, these vascular changes may 
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increase susceptibility to orthostatic hypotension but identification of their link 
with hypovolemia requires further study. 
Countermeasures have been developed to reduce and remove the risk of 
orthostatic hypotension following spaceflight.  NASA has created a 
countermeasure that attempts to restore lost plasma volume by administration of 
salt tablets and water prior to re-entry.  There are questions regarding the 
efficacy of this countermeasure which still need to be addressed.  
Ground-based analogues have been developed that allow researchers to 
investigate cardiovascular deconditioning in a controlled, economical, and 
flexible laboratory setting.  Six-degree head-down bed-rest (HDBR) has been 
shown to be an analogue to spaceflight as it removes the gravity vector directed 
from the head to the feet and induces a similar cephalad fluid shift as seen in 
spaceflight (Fortney Schneider and Greenleaf 1996). 
 This study investigated the effects of hypovolemia on cardiovascular 
deconditioning and the efficacy of NASA‟s fluid loading countermeasure in 
restoring both plasma volume and preventing cardiovascular deconditioning 
using the 6 ̊̊ HDBR model. 
1.1 SPACEFLIGHT AND BED-REST INDUCED HYPOVOLEMIA  
One of the earliest observations of space physiology was that microgravity 
causes a fluid shift towards the upper body. In space astronauts exhibit 
„chicken‟ legs and puffy faces since gravity no longer pushes blood towards the 
feet. With the cephalad displacement of fluid, water and sodium are excreted 
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from the kidney resulting in hypovolemia within the first hours of spaceflight. 
The Spacelab Life Science Missions reported a 10% plasma volume reduction 
during spaceflight (Sawka 1999). Bed-rest results corroborate the results from 
spaceflight (Vernikos and Convertino 1994, Waters 2004). This cephalad fluid 
shift results in immediate increases in central venous pressure, stroke volume 
and cardiac output. Within a few hours of exposure there is salt and water 
diuresis, reducing central venous pressure and stroke volume below supine 
values (Sawka 1999).  
Natochin and colleagues (1991) hypothesized that adaptation to 
microgravity causes a resetting of the fluid volume regulation system. The renal 
response to antidiuretic hormone, aldosterone, urodilatin, and atrial natriuretic 
peptide may be reset with spaceflight and bed-rest. The central venous pressure 
set point also appears to be lower with exposure to microgravity. Urine output 
during saline loading in ambulatory subjects was not altered by head-down bed-
rest. These factors may increase water clearance, and result in a lower set-point 
for body fluid balance. 
Convertino and Cooke hypothesize that the effects of hypovolemia may 
be a major factor in onset of presyncope following spaceflight by leading to 
reductions in vasoconstrictor reserve (Convertino and Cooke 2007). They 
speculate that if fluid volume is effectively restored, vasoconstrictor reserve 
will also be restored, providing adequate increases in peripheral resistance and 
prevention of orthostatic hypotension. 
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Hypovolemia is suspected to cause attenuation of cardiopulmonary and 
arterial baroreflex function, impairing baroreflex mediated responses to 
maintain blood pressure during orthostatic stress (Iwasaki et al. 2000, Vernikos 
and Convertino 1994). It is also suspected to negatively impact cardiac function 
by reducing preload (Perhonen et al 2001). 
1.2 REDUCTION IN VASOCONSTRICTOR RESERVE 
Diminished vascular function is suspected to be a major contributor to 
orthostatic hypotension. Following spaceflight and bed-rest, a reduced 
vasoconstrictor response is often seen during orthostatic challenge compared to 
pre-flight. In a group of astronauts returning from scientific missions on 
Spacelab, there were no statistical differences in circulating blood volume, 
blood pooling in the legs, reduced cardiac filling, stroke volume, or tachycardia 
compared to their pre-flight responses.  However, only five of the 14 astronauts 
were able to successfully complete a 10-minute stand test that each had 
completed pre-flight The feature that distinguished finishers from nonfinishers 
was the ability to maintain mean arterial pressure and increase their vascular 
resistance response (Buckey et al 1996).  Similar results relating reduced 
peripheral resistance responses to syncope following spaceflight were found in 
studies of astronauts by Fritsch-Yelle (1996), Meck (2004), and Waters (2002). 
In a 2-week bed-rest study, Zhang and colleagues found that an increase in 
vasoconstrictor outflow to muscle was attenuated during orthostatic testing 
following bed-rest. Cerebral autoregulation was also impaired, illustrated by an 
earlier and greater fall in cerebral blood flow velocity during orthostasis after 
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bed-rest (Zhang 2001). Arbeille and colleagues expanded these results, 
measuring femoral, renal, and cerebral vascular resistance in cosmonauts during 
short term and 3-month space travel.  At rest, post-flight femoral and renal 
vascular resistances were reduced and cerebral resistance didn‟t differ 
statistically from pre-flight values. Cerebral blood flow was maintained at pre-
flight values. During orthostatic challenge femoral vascular resistance was 
attenuated following spaceflight and the ratio between cerebral and femoral 
blood flow velocity was attenuated (Arbeille 1995). These studies suggest that 
failure to elevate peripheral resistance may contribute to a reduction in 
orthostatic tolerance after exposure to microgravity. 
Convertino describes syncopal and nonsyncopal responses as two 
different physiological states.  During a nonsyncopal response there is an 
increase in sympathetic stimulation that leads to an increase in total peripheral 
resistance (TPR) enabling mean arterial pressure to be maintained.  During 
severe hypotension there is an abrupt sympathetic withdrawal and subsequent 
vasodilation, causing a loss of blood pressure control and onset of syncope 
(Convertino and Cooke 2006). 
 One hypothesis regarding onset of syncope following exposure to 
microgravity and the reduced TPR response in nonfinishers is that bed-rest and 
spaceflight induce a change in vasoconstrictor reserve. Vasoconstrictor reserve 
is defined as the difference between baseline and maximum vasoconstriction. 
Rather than changes in vascular responsiveness, syncope may result when an 
 6 
individual does not have enough vasoconstrictor reserve to enable adequate 
TPR (Convertino and Cooke 2006). 
 There is evidence supporting the idea that each individual has a finite 
maximal vasoconstriction which is unchanged with exposure to microgravity. 
In a study investigating use of maximal exercise as a countermeasure, 
Convertino and colleagues showed that maximal vascular resistance does not 
change with 16 days of bed-rest (Engelke et al.1996, Convertino and Cooke 
2007). 
 Rather than a change in maximal vasoconstriction, there is evidence that 
exposure to microgravity elevates supine total peripheral resistance compared to 
pre-flight or bed-rest.  This elevation is thought to be due to hypovolemia and a 
lower circulating blood volume. An elevated baseline peripheral resistance 
results in a smaller capacity to constrict resistive vessels and therefore a lower 
vasoconstrictor reserve (Convertino and Cooke 2006). Convertino studied 8 
subjects in 16 day bed-rest with orthostatic testing occurring pre and post-bed-
rest. As orthostatic stress was increased, central blood volume was reduced, and 
peripheral vascular resistance was increased until maximal vasoconstriction was 
achieved (seen as a plateau in forearm vascular resistance with increasing 
orthostatic stress). Maximum vasoconstriction was unaltered with bed-rest, but 
it was reached at a lower orthostatic stress compared with pre-flight. Baseline 
resistance was elevated, reducing the vasoconstrictor reserve available to 
support orthostasis (Convertino 1999). 
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 Another method to examine reduced vasoconstrictor reserve is to 
investigate the cardiopulmonary baroreflex-mediated changes in forearm 
vascular resistance in response to changes in central venous pressure 
(∆FVR/∆CVP). Convertino and colleagues (1994) found that this relationship 
was elevated following exposure to microgravity.  Vascular responsiveness (the 
ability to vasoconstrict) is not compromised, as this would be reflected by 
attenuation of the ∆FVR/∆CVP relationship. 
 Investigators have examined if hypovolemia is a primary cause of the 
reduction in vasoconstrictor reserve.  Thompson and colleagues induced a 16% 
reduction in plasma volume by furosemide administration. Acute hypovolemia 
was associated with at 25% reduction in supine total peripheral resistance 
compared with normovolemia and an upward shift of the vasoconstriction 
response to orthostatic stress (Thompson 1990). Fu and colleagues induced an 
11% reduction in plasma volume by furosemide and found it was related to a 
67% reduction in vasoconstrictor reserve and a 35% reduction in tolerance time 
(Fu et al 2004). Vernikos and Convertino (1994) found that 7 days of bed-rest 
induced a 12% plasma volume reduction. The cardiopulmonary baroreflex 
response (∆FVR/∆CVP) following bed-rest had a higher slope than pre-bed-rest 
conditions. This indicates a greater utilization of the vasoconstrictor reserve, 
and that subjects are operating closer to their maximal vasoconstriction limit. 
Plasma volume restored by fludrocortisone also restored cardiopulmonary 
baroreflex function. Oral administration of salt and water did not restore plasma 
volume fully, nor did it restore cardiopulmonary baroreflex function. These data 
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provide evidence that hypovolemia may be responsible the reduction in 
vasoconstrictor reserve. 
These findings raise the possibility that hypovolemia resulting from bed-
rest and spaceflight may be a primary mechanism of orthostatic intolerance via 
reductions in vasoconstrictor reserve. Research is needed to investigate if 
similar results can be found with short term bed-rest and whether or not 
NASA‟s fluid loading protocol can prevent the reduction in vasoconstrictor 
reserve. 
1.3 ARTERIAL BAROREFLEX ATTENUATION 
Attenuated arterial baroreflex control of arterial blood pressure may lead to a 
reduced tachycardia response with orthostasis and be a cause of orthostatic 
hypotension following spaceflight and bed-rest. Fritsch-Yelle and 
colleagues found that orthostatic tolerance was decreased in 16 astronauts who 
experienced 4-5 days of spaceflight and this was accompanied by an attenuated 
baroreflex. The slope, range, and operational points of the carotid transmural 
pressure-sinus node response were reduced post-flight compared to pre-flight.  
The results illustrated functionally relevant reductions in parasympathetic and 
increases in sympathetic influences on arterial pressure control after spaceflight 
(Fritsch-Yelle et al 1994). 
Harrison has suggested that central blood volume changes may be 
responsible for altered carotid baroreflex responses because head down tilt 
reduces and head up tilt increases R-R interval responses to neck pressure 
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stimuli (Harrison 1986). It is not known whether attenuated arterial baroreflex 
function following exposure to microgravity is due to hypovolemia or a unique 
adaptation of the autonomic nervous system.  
Iwasaki et al. examined the link between arterial baroreflex attenuation 
and hypovolemia by comparing the effects of acute hypovolemia and bed-rest 
(deconditioning plus hypovolemia).  Nine healthy subjects underwent 2 weeks 
of 6º HDBR as well as acute hypovolemia induced by furosemide.  Both 
protocols induced the same reductions in plasma volume.  Power spectral and 
transfer function analysis investigated the relationship between R-R interval and 
systolic blood pressure (SBP).  Iwasaki et al. found that there were no 
significant differences between the effects of the 2 protocols in terms of cardiac 
filling pressures, arterial pressure, cardiac output, or stroke volume.  
Normalized high frequency power in the 0.15-0.25 Hz region of the R-R 
interval signal was attenuated to the same degree in both protocols, illustrated 
similar degree of vagal withdrawal.  Arterial-cardiac sensitivity, assessed by 
SBP to RR-interval transfer function gain, was reduced to a similar extent in 
both conditions. The ability of the baroreflex to alter blood pressure by 
modifying systemic flow, assessed by BP to cardiac output, was also reduced 
by both protocols. These results support the hypothesis that reductions in 
plasma volume may be a primary contributor to arterial baroreflex attenuation 
following bed-rest (Iwasaki et al 2000). 
Convertino and colleagues (1990) studied carotid baroreceptor-cardiac 
reflexes in 11 healthy men before, during, and after 30 days of bed-rest to test 
 10 
the hypothesis that baroreflex malfunction contributes to orthostatic intolerance 
and is related to hypovolemia. Sigmoidal baroreflex responses were provoked 
with a neck chamber device. Baseline R-R intervals and the minimum, 
maximum, range and maximum slope of the RR interval-carotid pressure 
relationships were reduced with bed-rest. The four subjects who experienced 
syncope during standing following bed-rest exhibited larger reductions in slope 
than the six subjects who completed the stand test. Non-syncopal subjects 
maintained the same systolic pressure before and after bed-rest, whereas the 
syncopal subjects experienced a significant reduction.  Although plasma 
volume declined by 15% there were no significant correlations between 
hypovolemia and changes of baroreflex response; plasma volume reductions 
stabilized after 2 days but baroreflex sensitivity continued to deteriorate 
throughout bed-rest. Bed-rest leads to substantial and progressive impairment of 
baroreflex function and that the progressive impairment of baroreflex 
malfunction is related significantly to the occurrence of orthostatic hypotension 
(Convertino 1990). 
The different results found by Convertino and Iwasaki may be attributed 
to the method of arterial baroreflex investigation. Transfer function analysis is 
thought to reflect both the aortic and carotid‐cardiac loops of arterial baroreflex 
control, however the neck chamber technique reflects only the carotid‐cardiac 
loop. It is possible that the loops adapt uniquely and independently to 
spaceflight and bed‐rest. The neck chamber technique is considered to 
investigate the static index of baroreflex function whereas the transfer function 
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gain provides insight into the dynamic properties of baroreflex function 
(Iwasaki et al 2000). The conflicting results may also be due to differences in 
acute and long term changes in blood volume. 
Vernikos and Convertino (1994) investigated the effects of hypovolemia 
on arterial baroreflex function. Arterial baroreflex was attenuated following 7 
days of bed-rest and a 12% reduction in plasma volume. When fluid volume 
was restored fully by fludocortisone administration, arterial baroreflex function 
was restored. Fluid volume restoration was also attempted by saline loading, 
however the prescription was insufficient to fully restore plasma volume to pre-
bed-rest levels (Vernikos and Convertino 1994). 
In order to gain insight into the rapidity of baroreflex attenuation and to 
further investigate the role of hypovolemia, a short duration bed-rest study 
examining the effects of fluid loading would be valuable. 
1.4 ALTERED SYSTEMIC BLOOD DISTRIBUTION 
There is a growing body of evidence that suggests systemic blood flow 
distribution is altered following exposure to microgravity. Increased 
vasoconstriction during orthostasis enables blood to be directed to the cerebral 
vasculature to maintain orthostasis. However, it appears that vasoconstriction 
responses vary across different various body compartments as a result of 
cardiovascular deconditioning following bed-rest. Specifically, there is 
evidence for different vasoconstriction responses between the systemic 
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circulation and the splanchnic region. Differential vasoconstriction may hinder 
cerebral blood flow availability and be associated with orthostatic intolerance. 
Arbeille and colleagues (2005) identified the portal vein as a valuable 
blood vessel to image as it is the only output from the splanchnic vascular area. 
Increases in portal flow reflect reductions in splanchnic vasoconstriction. This 
study also found that portal flow was increased following 90 days of bed-rest. 
This indicates that splanchnic arterial vasoconstriction was reduced with bed-
rest, which was associated with orthostatic intolerance. 
Fischer and colleagues (2007) found that total peripheral resistance was 
not altered with 4 hour bed-rest, but splanchnic blood flow was increased at 
each level of orthostatic stress after bed-rest compared to pre-bed-rest. This 
impaired ability to distribute blood away from the splanchnic region during 
orthostasis was associated with reductions in stroke volume and heart rate, and 
affected the ability to control arterial blood pressure. 
Compliance has been investigated by various space and bed-rest studies 
in the past as a source of blood pooling in the venous system.  Compliance 
increases following exposure to bed-rest and spaceflight, allowing for increased 
pooling and reductions in venous return. Compliance is thought to be an 
adaptation independent of hypovolemia and linked to muscle atrophy 
(Convertino 1989, Louisy 1997). 
Further investigation is needed to clarify altered systemic blood 
distribution with exposure to bed-rest. Knowledge of compliance and 
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differential vasoconstrictor responses also provide additional insight into 
systemic blood flow changes with bed-rest, and will be useful to provide 
understanding of the other measured variables. 
1.5 REDUCTION IN CARDIAC FUNCTION 
Cardiac muscle is extremely plastic and adapts to changes in volume or 
pressure loading. Spaceflight and bed-rest are models where the heart 
experiences unloading due to hypovolemia.  The heart experiences a lower 
filling pressure, resulting in reduced pre-load and myocardial work. Perhonen 
and colleagues (2001) have shown that exposure to bed-rest and spaceflight has 
led to cardiac atrophy. M-mode echocardiography performed on Skylab-4 
astronauts showed an 8% reduction in LV mass in four astronauts during an 84-
day mission (Henry 1977). Using the bed-rest model, left ventricular (LV) mass 
decreased in 5 sedentary men by 8% in 6 weeks, and 15.6% in 12 weeks.  No 
changes were seen in the control population who were ambulatory for the same 
duration.  The reduction in LV mass was associated with a reduction in wall 
thickness.  LV end-diastolic volume was decreased by 14% after 2 weeks and 
was sustained until bed-rest completion. This study utilized magnetic resonance 
imaging for cardiac measures, providing more precise measurements than 
echocardiography performed previously. Both bed-rest and spaceflight resulted 
in reductions in cardiac output and stroke volume which may result in 
orthostatic hypotension (Perhonen et al 2001). 
Cardiac atrophy was studied in direct reference to hypovolemia to 
determine if reductions in stroke volume are the due a cardiac adaptation to 
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head-down bed-rest or to acute hypovolemia alone. With hypovolemia alone 
baseline LV end-diastolic volume decreased by 7%, whereas after 2 weeks of 
bed-rest it decreased by 20%. Therefore both hypovolemia and cardiovascular 
deconditioning play a role in reduced cardiac function. 
 Though significant cardiac remodeling does not likely occur within the 
first day of bed-rest, heart function may be reduced due to hypovolemia. 
Lollgen (1984) found no changes in stroke volume and ejection fraction with 2 
hours of bed-rest, despite an increase in preload, indicating left ventricular 
function was not disturbed . However, these durations were too short to induce 
hypovolemia. Waters and colleagues (2004) studied the effects of fluid volume 
restoration following 14 days of bed-rest. With fluid restoration there were no 
changes in end-systolic and end-diastolic diameters, stroke volume or ejection 
fraction compared to pre-bed-rest conditions. However, the effects of bed-rest 
without fluid volume restoration were not examined so the extent of 
deconditioning that occurred with bed-rest is not known. 
 A short-duration bed-rest study in which both hypovolemia and fluid 
volume restoration are examined is needed to clarify the role of hypovolemia on 
reduced cardiac function in the absence of cardiac remodeling. 
1.6 HYPOVOLEMIA AND FLUID-VOLUME RESTORATION 
In order to identify the impact of hypovolemia as a primary mechanism 
affecting orthostatic hypotension, two studies have investigated whether a fluid 
loading protocol might restore fluid volume lost during bed-rest and improve 
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the cardiovascular response to orthostasis.  These studies have yielded 
conflicting outcomes.   
Vernikos and Convertino (1994) studied the effects of fluid volume 
replacement following 7 days of 6º head-down bed-rest using saline in a dosage 
of 8g of NaCl and 960 ml water. Saline loading was ineffective at both restoring 
plasma volume to baseline levels and preventing orthostatic hypotension. 
Plasma volume decreased by 12% with 7 days of bed-rest, but was not restored 
by saline. Four of the five subjects treated with the saline countermeasure 
experienced syncopal symptoms with failure to maintain stroke volume and 
mean arterial pressure during the post-bed-rest orthostatic challenge.  This was 
accompanied by compromised arterial and cardiopulmonary baroreflexes. Heart 
rate was increased following bed-rest despite saline loading and a reduction in 
peripheral resistance for the same drop in central venous pressure after bed-rest 
suggested that vasoconstrictor reserve was reduced. This study was limited by 
the lack of comparison between subjects‟ natural response to bed-rest and their 
response following fluid load (Vernikos and Convertino 1994). Also, a pre-
determined fluid load was given to all subjects despite variation in body mass, 
with subjects receiving less salt and water then prescribed by NASA‟s official 
fluid loading protocol. This may have prevented full volume restoration in 
subjects whose weight exceeded 64 kg (Waters et al 2004). 
Waters and colleagues (2005) found promising results with fluid loading 
as a countermeasure prior to orthostatic challenge after 12 days of 6º head-down 
bed-rest. Fluid loading was achieved with the standard NASA fluid loading 
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protocol of oral consumption of 1 g salt tablet per 125 ml water with a total 
volume of 15ml/kg within a 2 hour period prior to orthostatic challenge. The 
average blood and plasma volume losses, respectively, of 5% and 8% following 
bed-rest were restored to baseline with the fluid load.  No subject experienced 
syncope.  Heart rate increased following bed-rest despite the fluid load. All 
other measured variables (mean arterial pressure, cardiac output, stroke volume, 
ejection fraction, central venous pressure, and peripheral resistance) did not 
change with bed-rest. These results suggest that the latter cardiovascular 
variables and orthostatic hypotension are affected secondarily to hypovolemia. 
The important limitation of this study is the lack of investigation into the 
subject‟s natural bed-rest responses without fluid load because responses to 
orthostatic stress were only measured following fluid load. Therefore it cannot 
be said that fluid loading improved the subjects‟ responses to orthostatic stress 
following bed-rest.   
To clarify the cardiovascular responses to bed-rest and its resulting 
hypovolemia as well as the efficacy of NASA‟s fluid loading protocol, the 
following study was performed. 
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2 PURPOSE OF STUDY 
A 28h bed-rest study will be performed with 3 objectives: 
1.  To study the cardiovascular effects of 28h bed-rest, with specific 
consideration to the magnitude of the resulting plasma hypovolemia 
and mechanisms contributing to cardiovascular deconditioning. 
2.   To examine the effectiveness of NASA‟s fluid loading protocol on 
restoring lost plasma volume to its initial value after 28h bed-rest 
and to determine if this countermeasure reduces susceptibility to 
cardiovascular deconditioning. 
3.  To isolate the circadian effects of head-down bed-rest and fluid 
loading on plasma volume and cardiovascular deconditioning by 




1. Plasma volume will be significantly reduced from baseline 
following 28 hour bed-rest. 
2. Plasma volume will be restored by NASA‟s fluid loading protocol. 
Cardiovascular Deconditioning 
1. Cardiovascular deconditioning will result following 28 hour bed-
rest, manifested by reductions in stroke volume, cardiac output and 
central venous pressure, as well earlier onset of tachycardia during 
orthostatic challenge post bed-rest.  
2. Some subjects will experience pre-syncopal symptoms (loss of 
blood pressure maintenance) during post bed-rest orthostatic testing. 
3. Cardiovascular deconditioning will be prevented with fluid loading.  
Post bed-rest stroke volume, cardiac output, central venous 
pressure, and onset of tachycardia will not significantly differ from 
pre bed-rest results.   
4. Subjects who experienced pre-syncopal symptoms during the non-
fluid-loading protocol will not experience pre-syncopal symptoms 
with fluid loading. 
Vasoconstrictor reserve and Peripheral Resistance 
1. Vasoconstrictor reserve will be reduced with 28h bed-rest. This will 
be illustrated by an increased baseline peripheral resistance, an 
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increased slope of peripheral resistance response with levels of 
orthostatic challenge, and an attenuated cardiopulmonary baroreflex 
response (∆ forearm vascular resistance/ ∆ central venous pressure). 
2. Vasoconstrictor reserve will be restored with fluid loading. The 
baseline peripheral resistance, the peripheral resistance response to 
orthostatic challenge, and the cardiopulmonary baroreflex response 
following bed-rest and fluid loading will not significantly differ 
from baseline. 
Arterial Baroreflex Sensitivity 
1. Arterial baroreflex sensitivity will be attenuated following 28 hour 
bed-rest.  
2. Arterial baroreflex responses will be restored with fluid loading. 
Cardiac Measures 
1. Ejection fraction will be reduced with 28 hour bed-rest and 
orthostatic challenge. 
2. Ejection fraction at baseline and during orthostasis will be restored 
with fluid loading.  
Systemic Blood Distribution 
1.  Splanchnic vasoconstriction and total peripheral vasoconstriction 
responses will differ; splanchnic vasoconstriction is expected to 
decrease following bed-rest where as total peripheral resistance is 
expected increase. 
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2.  Fluid loading will not restore differential vasoconstriction responses 
between the total peripheral resistance and splanchnic resistance. 
3. Venous compliance will be increased with 28 hour bed-rest. 




This study examined 9 male subjects between the ages of 18 to 33 years old. 
Subjects completed a medical questionnaire prior to participation, which 
informed the examiners of their health status, prescribed medications, time of 
last blood donation, and fitness level. All subjects were free of cardiovascular 
illness. None of the subjects had taken prescription or non-prescription 
medication during the days prior to testing. The regular daily activity levels of 
the subjects varied considerably, with subjects‟ lifestyles ranging from low 
fitness levels to daily training.  
Prior to testing, subjects were familiarized with the laboratory 
equipment and the study protocol to reduce stress during the first test. Subjects 
were screened for portal vein imagery before their first test. All subjects read 
and signed a consent form authorized by the University of Waterloo‟s Office of 
Research Ethics prior to participation.   
4.2 PROTOCOL 
This study had a randomized crossover design; all subjects completed each 
treatment and control.  The protocol included two 28h head-down bed-rest 
(HDBR) treatment tests: 28h FL HDBR (with fluid loading) and 28h NFL 
HDBR (without fluid load), as well as three 4-hour control tests: 4h S NFL 
(seated), 4h S FL (seated with fluid load), and 4h HDBR. These tests are 
described in detail in Section 4.3. Table 4.2-1 below indicates the order in 
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which each subject performed each test (1= first test completed and 5= last test 
completed), and confirms that the randomized cross-over design was 
performed. 
Table 4.2-1: Order of Test Completion 




4h S NFL 4h S FL 4h HDBR 
1 1 5 4 2 3 
2 5 4 2 1 3 
3 3 4 5 1 2 
4 5 4 3 1 2 
5 2 1 5 3 4 
6 2 5 3 4 1 
7 5 4 3 1 2 
8 4 5 1 3 2 
9 4 5 2 3 1 
 
It is noted that the 28h FL HBDR test was frequently performed later in 
the testing sequence. Several constraints determined the order in which testing 
was performed. Subjects' school and work schedules played a large role. Three 
participants were competitive swimmers, and test scheduling took into 
consideration their training and competition obligations due to the time 
commitment of each test and the volume of blood collected during each test. 
Another major determinant of test order was that the data from two of the 4-
hour tests (4h S NFL and 4h HDBR) were shared with another project. Data 
collection for the other study began prior to data collection from this study, 
meaning that often data from the two aforementioned tests was collected prior 
to the 28h NFL HDBR, 28h FL HDBR, and 4h S FL tests. 
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 Each testing session began at 7 am to control for the effects of circadian 
rhythm. At least 1 day of recovery was required after a 4-hour test and 7 days 
after a 28h test before another test was performed. This allowed for red blood 
cell replacement after blood collection. 
4.3 28H TREATMENT MODELS 
The subjects were tested under the conditions specified by two 28h treatment 
models: 
1. 28h non-fluid loading HDBR model (28h NFL HDBR) 
2. 28h fluid loading HDBR model (28h FL HDBR) 
The 28h NFL HDBR model was designed to investigate the natural 
cardiovascular response to orthostasis following 28 hours of bed-rest. The 28h 
FL HDBR test was designed to examine the cardiovascular responses to 
orthostatic stress following 28 hours of bed-rest while employing NASA's fluid 
loading protocol during the final 2.5 hours of bed-rest exposure.  
The 28h test protocols are illustrated by Figure 4.3-1. Upon arriving at 
the lab, the subject was prepared for the test with measurements of height and 
weight, morning urine collection, and electrode placement for ECG and 
impedance plethysmography. The subject‟s baseline total blood and plasma 
volumes were measured during the carbon-monoxide (CO) re-breathe. Baseline 
cardiovascular responses to cardiovascular stress were then collected during a 
low-body negative pressure (LBNP) test. The subjects then underwent 28 hours 
of 6° HDBR. After HDBR, a second "Post" LBNP test examined the effects of 
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the protocol. During the fluid loading model, the prescribed treatment took 
place between 25.5 and 27.5 hours, with the intention to restore plasma volume 
to its pre-bed-rest values.  
 
 
Figure 4.3-1: Timeline for 28h HDBR Treatment Models 
Food consumption was scheduled after blood sampling and at least 3 
hours prior to portal imagery in order to minimize the effects of food intake on 
these measurements. Subjects' sleep schedules were planned for 8 hours, 
between 10 pm and 6 am. Blood draws for hematocrit measurements are 
indicated by arrows in Table 4.2-1. Times when urine collection and defecation 
were permitted are also indicated. Urine collection was permitted throughout 
testing, except during LBNP testing and the CO re-breath. Defecation was not 
allowed within the final 4 hours of HDBR to prevent exposure to ambulation 
and gravity. Following the post-LBNP test, height and weight was measured 


























































































































































































4.4 4-HOUR CONTROL MODELS 
The subjects were also tested under the conditions specified by three 4-hour 
control models: 
1. 4-hour seated non-fluid loading model (4-hour S NFL) 
2. 4-hour seated fluid loading model (4-hour S FL) 
3. 4-hour HDBR non-fluid loading model (4-hour HDBR) 
The 4-hour S NFL and 4-hour HDBR models were used to determine 
whether the cardiovascular changes in the 28 hour models were affected by the 
time of day. The 4h S FL model was compared to the 4-hour S NFL model to 
isolate the effects of the fluid loading protocol in the non-HDBR condition. The 
4-hour S FL protocol was also compared with 28h FL HDBR results to isolate 
the effects of bed-rest in the 28h tests.  
Figure 4.4-1 illustrates the timeline for the 4 hour control models. 
Testing was designed to mimic the 28 hour tests, with fluid loading scheduled 
between 1.5 and 3.5 hours. Lunch was scheduled after the first blood sample (0 
hour) taken during the bed-rest or seated period, to control for its effects on 
hormones and portal blood flow measurements. Blood draws for hematocrit 
measurements and times for urine collection and defecation are also indicated in 
Table 4.4-1. Defecation is not permitted within the 4 hour model to prevent 














Figure 4.4-1: Timeline for 4-hour Control Models 
4.5 LOWER-BODY NEGATIVE PRESSURE BOX (LBNP) TESTING 
Lower-body negative pressure (LBNP) testing is a method of exposing a subject 
to the cardiovascular effects of orthostasis in a safe manner. The LBNP box is 
composed of a box with an opening for the subject to enter feet-first with an 
attachment for a kayak skirt that creates a seal at the subject‟s waist. The closed 
system is connected to a vacuum which regulates pressure inside the box via a 
voltage regulator. One of the major advantages of this method of orthostatic 
testing compared to tilt or stand tests is that it removes the effects of the muscle 
pump, therefore allowing examination of blood pressure regulation solely by 
cardiovascular responses. It is also safe since the subject remains in the supine 
position and the suction can be immediately removed if pre-syncopal symptoms 
























































































































This study used a progressive LBNP test to measure its subjects' 
response to orthostatic challenge: 0 mmHg (5min), -10 mmHg (3 min), -20 
mmHg (5 min), -30 mmHg (3 min), and -40 mmHg (5 min).  Subjects were 
placed in the box in the supine position for at least 20 min prior to the start of 
the LBNP test during equipment set-up to stabilize their physiological 
condition.  Signals directly indicating the stability of blood pressure regulation, 
such as heart rate, mean arterial pressure, and systolic blood pressure, were 
monitored continuously throughout the progressive test for monitoring of the 
subject‟s condition and data collection. Brachial blood flow and cardiac output 
were also measured continuously. Aortic blood flow and cardiac impedance, 
used in calculations of cardiac output, were measured at specific times 
throughout each level as described in Figure 4.5-1.  Ultrasound imaging of 
portal vein and inferior vena cava were measured separately from aortic blood 
flow to prevent acoustical interference. Splanchnic impedance was collected 
during this time since it was used in conjunction with portal vein measurements 
to describe splanchnic hemodynamics.  Blood was collected between 3:15 and 
5:00 min of 0, -20 and -40 mmHg segments, and therefore this was the only 
time when central venous pressure was not collected due to use of the same 
catheter.  Echocardiography was tested at 0 and -40 mmHg. In order to reduce 
stress on the subject, echocardiography at 0 mmHg was done before the LBNP 
test commenced (during the setup period), and at -40 mmHg following a 1 min 
recovery period at 0 mmHg  following the progressive test in order to minimize 
stress on the subject.  In the event the subject was unable to complete the LBNP 
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test, echocardiography was performed at -30 mmHg instead, or not collected. 
The LBNP protocol used in this study is described by Figure 4.5-1.  
 
Figure 4.5-1: LBNP Testing Protocol 
4.5.1 Test Termination Criteria 
In order to protect the subjects, the following procedures were in place to 
terminate LBNP testing before syncope occurred: 
1.  Fall in systolic blood pressure < 70 mmHg (or reduced by 25 mmHg   
from baseline) 
2.  Rapid drop in mean arterial pressure or heart rate 
3.  Symptoms of stomach awareness, nausea, sweating, narrowing of 
visual field, or dizziness 
During bed-rest period, many subjects experienced back pain, 
restlessness, and light headaches. The subjects had to option to abort the test at 
any point if they felt extreme discomfort; however no subjects chose to end the 
test prematurely. 
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4.6 HDBR AND SEATED POSITIONS 
In protocols using the HDBR position, the subject was placed in a 6 ̊ head-down 
position for the duration of the test. The objective of this position was to mimic 
microgravity by inducing a fluid shift from the feet towards the upper body.  
The subject remained in this head-down position for all activities including 
eating, drinking, sleeping, and urination. The only exception during the 28 hour 
tests was defecation, when the subject was permitted to use the washroom. No 
exercise was performed by the subjects during the testing period. The HDBR 
position is shown in Figure 4.6-1. 
 
Figure 4.6-1: HDBR Position 
During seated tests the subject was seated in a comfortable chair with 
their head and torso above their legs. The subject remained in the seated 
position for all activities including eating, drinking, sleeping, and urination. No 
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exercise was performed in the seated position. The seated position is illustrated 
in Figure 4.6-2. 
 
Figure 4.6-2: Seated Position 
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4.7 FLUID LOADING PROTOCOL 
During protocols involving fluid loading, subjects underwent NASA‟s fluid 
loading protocol.  The intent of this protocol was to restore lost fluid volume 
resulting from bed-rest with a hypotonic solution that could be easily performed 
by astronauts returning from space. Water and salt was ingested in a dosage of 
15 ml/kg with a 1g salt tablet for each 125 ml water consumed (Waters 2004). 
The fluid loading protocol was performed between 1.5h and 3.5h (during the 4h 
protocol) and 25.5h and 27.5h (during the 28h protocol), as seen in Figures 4.3-
1 and 4.4-1.  Salt and water were administered in equal intervals across the fluid 
loading period. If the subject experienced stomach upset or nausea, fluid 
loading was paused or aborted to prevent loss of fluid by vomiting and subject 
discomfort. The impact of nausea is discussed thoroughly in Section 5.2. 
 
Figure 4.7-1: Fluid Load Salt Tablets and Graduated Water Bottle 
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4.8 ADDITIONAL TESTING CONSIDERATIONS 
4.8.1 PRE-TESTING CONSIDERATIONS 
Subjects were asked to complete a food diary for the three days prior to testing 
in order to gauge their sodium intake. For 24 hours prior to testing, subjects 
were asked to abstain from alcohol, caffeine, and heavy exercise. They were 
also provided with a list of sodium-rich foods to avoid.  It was requested that 
the subject consume the same breakfast prior to each test. The recommended 
breakfast was two slices of bread with 1 tbsp jam.  The subject was required to 
consume 5 ml of water per kg body weight the night before and the morning of 
testing to achieve a hydrated state, as done by Waters and colleagues (2004). 
During the 28h HDBR tests, the subject also consumed 5 ml/kg of water before 
bedtime and after waking up while in the lab. Monitoring of these requests was 
accomplished by a series of questions posed to the subject before the 
commencement of testing, and the submission of their food diary. 
4.8.2 SLEEP 
A pre-determined sleep schedule was adopted to control for circadian rhythm 
and provide a control measure for blood analysis.  An 8 hour block of time 
between 10 and 6 am was allocated for sleep. Sleep was not permitted at any 
other time. 
In practice, subjects often fell asleep between 10:30-11:00 pm and 
awoke between 6:30-7:00 am, although the "lights-out" occurred on time. Most 
of the subjects were accustomed to going to sleep later, and had not adapted 
before the study to the prescribed sleep schedule. It is also important to mention 
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that it was common for subjects to wake-up during the night due to back pain or 
discomfort, or to urinate. An investigator stayed overnight with the subjects in 
order to facilitate toiletry or discomfort needs.  
4.8.3 FOOD AND WATER INTAKE 
Breakfast, lunch, dinner, and snacks were provided to the subjects during each 
28h test period, and lunch was provided during each 4h test.  The menu was 
based on a standard 2500 calorie daily intake for males with a minimum sodium 
intake of 4g (174 mEq), similar to the diet used by Waters and colleagues 
(2004). It is described in Table 4.8-1. Each subject was given the same menu 
regardless of body size or daily physical activity. This approach was intended to 
keep caloric and salt constant across all subjects during each test and avoid 
addressing daily variation in subjects' weights. It was supported by the fact that 
none of the subjects were exercising during the experiment period.   
Table 4.8-1: Menu 
Meal Item Applicable Tests 
Breakfast  2 pc multigrain toast with 1 tbsp jam 
 5 ml/kg water 
 (or breakfast chosen by subject) 
 To be consumed at home 
by the subject prior to a 
4h or 28h test 
 Provided to subject 
during 28h NFL/FL 
HDBR tests 
Lunch  Turkey sandwich (2 pcs multigrain 
bread, mayonnaise, 2 turkey slices, 
tomato slice, lettuce) 
 All tests 
Afternoon 
Snack 
 Harvest Crunch granola bar 
 Orange Juice 
 28h NFL/FL HDBR 
Dinner  Spaghetti with meat balls 
 Yoghurt (fruit bottom) 
 500 ml Gatorade 
 2 g NaCl  




 Orange Juice 
 28h NFL/FL HDBR 
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It should be noted that the breakfast described in Table 4.8-1 is the 
suggested breakfast, however if subjects consumed a different breakfast in the 
morning of their first test, all subsequent breakfasts throughout testing were 
based on their first breakfast. 
A general observation was that subjects had an appetite during the first 
hours of the 28h bed-rest sessions, but their appetite diminished by dinnertime 
on the first day or breakfast on the second day of testing. Occasionally it was a 
struggle for subjects to finish dinner due to lack of appetite. No subjects 
complained that they wanted more food, and all subjects finished their meals. 
Water intake during the HDBR or seated portion of testing was 
controlled between hour 0 - hour 4 (4h and 28h tests) and hour 24 - hour 28 
(28h tests). This was to ensure subjects remained hydrated, but only ingested 
the water prescribed by the fluid loading protocol during the fluid loading 
period, and also to maintain consistency in fluid intake during these time 
periods across each of the subjects' tests. Subjects' water intake during the first 
completed test was ad libitum between hour 0 - hour 1.5, and hour 24 - hour 
25.5 (no water was ingested between 1.5 - 4 hours or 25.5 - 28 hours except for 
the prescribed fluid load). During subsequent tests the subjects were allowed to 
consume the amount of water consumed in their first session ± 25%. During 
28h tests, subjects could consume water freely between hour 4 and hour 24, in 
addition to the fluid prescribed by meal, and morning and evening hydration. 
Each evening and morning (including the night prior to testing and the night 
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spend in the lab), subjects consumed 5 ml/kg water in an effort to maintain 
hydration.   
4.9 MEASURED VARIABLES 
Table 4.9-1 below summarizes the raw data and that will be collected during 
testing its associated hardware. 
Table 4.9-1: Measured Variables 
Measured Variable Method 
Basic Cardiovascular Indicators 
ECG Colin 
Blood pressure  
(SBP, DBP, MAP, PP) 
Finometer 
Manual blood pressure Sphygmomoneter 
Vascular Data 
Cardiac output Finometer 
Aortic flow velocity Doppler multigon (2 MHz), peak flow velocity 
Brachial flow velocity Doppler multigon (4 MHz), mean flow velocity 
Splanchnic impedance Impedance plethysmography 
Central venous pressure Pressure transducer connected via water to 
catheter in antecubical vein; digital signal 
collected via Colin 
Lower body negative 
pressure 
Portable manometer connected to LBNP 
internal volume 
Brachial diameter Ultrasound (4 MHz probe; 2-D and M-mode) 
Aortic diameter Echocardiography (2 MHz probe; 2-D 
Parasternal Long Axis of Left Ventricle) 
Left ventricular function  
(ejection Fraction, stroke 
volume)  
Echocardiography (2 MHz probe; M-mode view 
of Parasternal Long Axis of Left Ventricle) 
Portal diameter and flow 
velocity 
Ultrasound (2 MHz probe; 2-D and Doppler) 
Inferior vena cava diameter Ultrasound (2 MHz probe; 2-D) 
Blood and Plasma Volume Measurement 
Blood volume 
measurement 
Carbon monoxide rebreathe and hematocrit 
measurements 
Urine volume Urine collection (ml) in graduated bottle and 
weight measurement 
Water intake Fluid intake measurement (ml) in graduated 
bottle 
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The LBNP test set-up is illustrated in Figures 4.9-1 and 4.9-2. 
 
Figure 4.9-1: LBNP Test Setup View 1 
 
Figure 4.9-2: LBNP Test Setup View 2 
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4.9.1 BLOOD PRESSURE AND HEART RATE 
Heart rate was continuously collected via the Colin using a 3 lead ECG.  
Electrodes were placed on the left and right upper chest below the collarbone 
with a grounding lead on the lower left abdomen, on the rib cage.  An excellent 
ECG signal was required as each “R” peak was identified in order to analyze 
data on a beat-by-beat basis.  
The Finometer provided a continuous arterial blood pressure signal and 
an estimation of cardiac output (Q).  MAP, SBP, DBP, and PP were determined 
from the blood pressure signal. The Finometer calibrated intermittently with 
“Physiocal”, which interrupted the continuous blood pressure data. Physiocal 
was turned off during the 0 mmHg, -20 mmHg, and -40 mmHg segments of 28 
hour tests to provide continuous data sets for spectral analysis of these data 
(which were used to analyze arterial baroreflex sensitivity as described in 
Section 4.9.9). A manual blood pressure measurement using a sphygmanometer 
was performed in the supine position before testing commenced as an additional 
Finometer calibration. 
The Finometer also provided a visual indication of heart rate and blood 
pressure trends over time and was used to monitor the subject's condition during 
the LBNP test and be aware if pre-syncopal symptoms were developing. 
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4.9.2 AORTIC AND BRACHIAL BLOOD FLOW 
Aortic blood flow data were collected to measure stroke volume and cardiac 
output at each level of LBNP during pre and post bed-rest testing. The 2 MHz 
probe was used to measure peak blood flow velocity from the ascending aorta. 
Aortic blood flow velocity was used in the calculations of stroke volume and 
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Aortic blood flow velocity data were collected during each level as 
described in Figure 4.5-1 to prevent interference with ultrasound imaging. Data 
was collected after a minute of exposure to each level of LBNP stress to ensure 
the body had fully adapted. Stroke volume and cardiac output measurements 
were divided by the subject‟s body surface area (BSA) to create a normalized 
variable for statistical analysis, as done by Waters and colleagues (2005). 
725.0425.0 )(*)(*007184.0 heightweightBSA   
Doppler ultrasound was used to obtain measurements of brachial blood 
flow velocity. The 4MHz probe was used to measure mean blood flow velocity 
through the brachial artery. Data were collected throughout each level of LBNP 
testing except when blood was drawn, as described in Figure 4.5-1.  Room 
temperature was maintained around 21°C to control for skin blood flow, which 
affected brachial blood flow measurements. Brachial blood flow was calculated 
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using brachial blood flow velocity with the equation on the following page, 















Brachial blood flow data was divided by the subject‟s arm volume to 
normalize the data for statistical comparison. Arm volume was measured by the 
water displaced by the arm between the subject‟s elbow and wrist (water 
displaced by whole forearm minus water displaced by hand).  
4.9.3 CENTRAL VENOUS PRESSURE 
Central venous pressure provided an indication of blood return to the heart and 
was used to explain reductions in stroke volume and cardiac output, as well as 
changes in compliance and cardiopulmonary baroreflex response with bed-rest 
(Fischer et al 2007, Waters et al 2005, Vernikos and Convertino 1994).  During 
LBNP testing, a pressure transducer (TranStar 152 cm Single Monitoring Kit) 
was connected to the catheter inserted in the antecubital vein via a continuous 
column of water. The pressure transducer was mounted on a laser level to place 
the transducer at the level of the heart, which provided a continuous indication 
of venous pressure at heart level.  CVP data was continuously collected 
throughout LBNP testing except during blood draws at the during the final 1.5 
minutes of 0 mmHg, -20mmHg, and -40 mmHg LBNP levels, as described in 
Figure 4.5-1. A visual description of the CVP apparatus can be sound in Figures 
4.9-1 and 4.9-2. 
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4.9.4 ECHOCARDIOGRAPHY  
Echocardiography was used to study changes in cardiac performance with 
exposure to bed-rest and orthostasis.  Data was collected using a 2 MHz 
ultrasound probe at 0 and -40 mmHg pre and post bed-rest. The 2-D parasternal 
long axis view of the left ventricle was used to measure the diameter of the 
aorta for calculation of cardiac output using aortic flow velocity.  M-mode of 
the parasternal long axis was used to calculate ejection fraction. Ejection 
fraction was defined as the percentage of blood volume pumped out of the left 
ventricle per beat. Left ventricular end-systolic volume (ESV) and end-diastolic 
volume (EDV) were calculated from left ventricular end-systolic and end-
diastolic diameters and used to determine ejection fraction using the following 







 The M-mode view of the parasternal long axis was also used to calculate 
fractional shortening, which describes the ratio of left ventricular diastolic 
diameter to left ventricular systolic diameter. A decrease in fractional 
shortening usually precedes a reduction in ejection fraction., and therefore 
fractional shortening can provide additional information on changing left 
ventricular performance. Fractional shortening was calculated by the following 








 During echocardiography, the table was tilted so that the subject‟s right 
shoulder was elevated, shifting the lungs to obtain a clear view of the heart.  In 
order to reduce stress on the subject and to change the subject‟s position, the -
40 mmHg measurement was taken after a brief recovery period at 0 mmHg, as 
described in Figure 4.5-1. The measurements were made after a minute of re-
exposure to -40mmHg to ensure adaptation to the level of orthostatic stress. 
Examples of 2-D and M-mode views of the parasternal long axis of the left 
ventricle are available in Figures 4.9-3 and 4.9-4.   
 
Figure 4.9-3: 2-D Echocardiography Image of Aortic Diameter 
 
Figure 4.9-4: M-Mode Echocardiography to Measure Ejection Fraction 
and Fractional Shortening 
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4.9.5 PORTAL VEIN, IVC AND BRACHIAL ULTRASOUND IMAGING 
Portal diameter and flow were used to examine splanchnic resistance and 
systemic blood distribution.  At each level of LBNP ultrasound images of portal 
vein diameter and portal vein Doppler flow velocity were obtained using the 2 
MHz probe to image between the ribs from a right lateral view. Blood flow 
through the portal vein was calculated from diameter imagery and Doppler flow 













   
Portal vein flow velocity was measured at the end of exhalation for 
consistency due to tissue movement.  Subjects had not eaten for 3 hours prior to 
imaging in order to minimize the effects of digestion. Figure 4.9-5 provides an 
example of portal vein imaging. 
 
Figure 4.9-5: M-mode Ultrasound of Portal Vein Flow Velocity 
Inferior vena cava diameter (IVC) measurements provided an indication 
of venous return to the heart.  Venous return is known to reduce with increasing 
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LBNP and bed-rest, and reductions in IVC diameter have provided evidence 
that supports direct right atrial pressure data.  IVC diameters were obtained 
using the 2 MHz ultrasound probe with a right lateral view through the ribcage. 
An illustration is provided in Figure 4.9-6 below. All diameter measurements 
were taken during systole. 
 
Figure 4.9-6: Ultrasound Image of Inferior Vena Cava Diameter 
Brachial diameter was used in brachial blood flow calculations as 
described in Section 4.9.2. Diastolic brachial diameter was measured at 0 
mmHg before commencement of the LBNP protocol using the 4 MHz probe. 
The probe was placed above the elbow of subject's right arm, in the same 
location where brachial blood flow velocity was measured during LBNP 
testing. Due to technical limitations, brachial diameter was not measured during 
the LBNP testing. An example of brachial imaging is provided in Figure 4.9-7. 
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Figure 4.9-7: Ultrasound Image of Brachial Diameter 
4.9.6 TOTAL PERIPHERAL RESISTANCE 
Total peripheral resistance (TPR) was estimated using cardiac output, mean 
arterial pressure, and central venous pressure, using the following equation 
below. Individual subject‟s data was normalized using their body surface area, 






4.9.7 ARTERIAL AND VENOUS COMPLIANCE 
Arterial and venous compliance were measured during LBNP testing. 
Compliance was defined as the ratio of changes in volume to changes in 
pressure. Venous compliance was measured as the ratio between the overall 
change in IVC diameter to the overall change in CVP measured between 0 and -
40 mmHg. An increase in this ratio reflected an increased venous compliance. 
Arterial compliance was calculated as the ratio of the overall change in stroke 
volume to the overall change in pulse pressure between 0 and -40 mmHg. An 
increase in this ratio reflected an increase in arterial compliance. 
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4.9.8 SPLANCHNIC IMPEDANCE 
Splanchnic impedance provided an indication of systemic fluid shifts occurring 
during application of lower body negative pressure, and was investigated by 
measuring the changes in resistance of the splanchnic segment. An increase in 
R was expected with orthostasis and LBNP since these conditions cause blood 
to move away from the splanchnic cavity towards the feet (Taneja 2007). 
Electrodes were placed between the xyphoid process and iliac crest to isolate 
regional blood volume shifts in the splanchnic compartment. Splanchnic 
impedance was measured during ultrasound imaging of the portal vein and 
inferior vena cava since these measurements were collectively used to describe 
fluid shifts. This is reflected in the timeline available in Figure 4.5-1. 
4.9.9 ARTERIAL BAROREFLEX  
The closed-loop arterial baroreflex regulation of blood pressure was 
investigated by transfer function analysis of continuous beat-by-beat R-R 
interval and systolic blood pressure data (SBP). Three- minute data sets were 
collected during 0, -20, and -40 mmHg levels of pre and post LBNP tests. 
Transfer function analysis yielded mean gain, phase, and coherence values of 
the SBP and R-R interval signals in the low (0.05-0.15 Hz) and high frequency 
ranges (0.15-0.25 Hz) (Iwasaki et al 2000). The low frequency range provided 
insight into sympathovagal balance, whereas the high frequency range studied 
cardiac vagal modulation of blood pressure. The transfer function gain reflected 
changes in R-R interval in response to changes in SBP mediated by baroreflex 
function.  Phase reflected the response time between spontaneous fluctuations 
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in SBP and changes in R-R interval control (Iwasaki et al 2000). Coherence 
indicated the degree of linearity between the two signals and therefore provided 
an indication of the merit of the gain and phase results; in order for transfer 
function analysis to be relevant the coherence was required to be at least 0.5 on 
a scale between zero and one.  This method was noninvasive and could be 
applied repeatedly within a short period of time. The method is highly 
correlated with traditional phenylephrine method of investigating baroreflex 
sensitivity (Robbe et al 1987). These data were divided by the total spectral 
power to provide a normalized value for statistical purposes (Montano et al 
1994, Pagani et al 1986). 
The primary limitation of this method was the short time period 
available during LBNP testing for collection of R-R Interval and SBP signals, 
since longer data sets provide a better indication of baroreflex function. In order 
to increase the accuracy of transfer function analysis and maximize continuous 
dataset length, the Finometer‟s “Physiocal” was turned off during the data 
collection period (between 1:30 - 4:30 minutes of the 5 minute time period at 0, 
-20, and -40 mmHg). Physiocal was on during the first 1:30 minutes and final 
30 seconds of the LBNP level to ensure accurate cardiac output data, which was 
important for another project that used the same data collection. If data points 
were missing during the last 30 seconds of each level (when Physiocal was 
turned on), the missing data points were estimated by linear interpolation from 
surrounding data points in order to have a continuous dataset.  
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4.9.10 CARDIOPULMONARY BAROREFLEX 
The cardiopulmonary baroreflex was examined in two ways. One 
method analyzed the relationship of forearm vascular resistance (FVR) versus 
central venous pressure (CVP). FVR was calculated as mean arterial pressure 
divided by brachial blood flow. Vernikos and Convertino (1994) showed that an 
attenuated cardiopulmonary baroreflex response was reflected by an increased 
slope of the FVR-CVP response. Changes in cardiopulmonary baroreflex 
response were also examined by changes in supine brachial diameter, brachial 
blood flow velocity and brachial blood flow with orthostatic stress. A 
significant difference in these variables in the supine position after bed-rest 
indicated resetting of the cardiopulmonary baroreflex. A change in the 
characteristic response curve of these variables with increasing orthostatic stress 
following bed-rest illustrated a change in cardiopulmonary baroreflex 
sensitivity due to bed-rest exposure. 
4.9.11 TOTAL BLOOD VOLUME AND PLASMA VOLUME 
A carbon monoxide (CO) rebreathe was performed at the beginning of each test 
to determine each subject‟s baseline total blood volume and plasma volume, in 
accordance with the methodology described by Burge and Skinner (1995). This 
method used CO to estimate total blood volume due to hemoglobin‟s strong 
affinity for the molecule. After a small dosage of CO was administered, a blood 
sample was analyzed to estimate the ratio of CO-bound hemoglobin, total 
hemoglobin, and hematocrit. These values were used to calculate total blood 
and plasma volume. Blood and plasma volume calculations depended on 
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pressure and temperature, which were recorded at commencement of the CO re-
breathe protocol. The CO-rebreathe method shows a 99% correlation to plasma 
volumes measured using 125I-labeled albumin (Burge and Skinner 1995). 
The protocol began with the subject breathing pure oxygen for ten 
minutes on an open loop system to expel nitrogen from their blood.  The subject 
was then switched to a closed loop system where the exhaled oxygen was 
recirculated. After the subject became accustomed to the increased resistance of 
breathing on the closed loop system, a small dose (~20 ml) of CO was inserted 
into the closed loop system. After 5 minutes of quiet breathing, which ensured 
maximal CO-Hb binding, a small blood sample was taken. A second blood 
sample was taken 5 minutes after a test dosage of ~70 ml administered. CO 
dosages varied slightly according to body size, with greater doses administered 
to larger individuals (i.e. 60 versus 80 ml). Carbon dioxide absorbers protected 
the subject from inhaling high concentrations of CO2.  During the rebreathe, the 
subject was only able to breathe from the system via a mouthpiece and 
biological filter. Nose clips and taping of the mouthpiece to the mouth 
prevented intake of outside air.  The subject‟s oxygen supply was constantly 
monitored. If the subject needed to abort the test, the nose clips were 
immediately removed and the test finished. There was one instance where a test 
was aborted prematurely due to subject discomfort.   
Monitoring of hematocrit throughout the protocol allowed for changes 
of blood and plasma volume to be easily tracked without the need for additional 
CO rebreathe tests. Blood was collected from a catheter inserted in the 
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antecubital vein of the right arm.  The catheter was inserted prior to the CO 
rebreathe test and removed following completion of the post-LBNP session.  
The catheter was also removed during the overnight portion of 28h testing for 
subject comfort. The timing of hematocrit measurements are indicated as 
arrows in Figures 4.3-1 and 4.4-1. Approximately 1 ml of blood was taken per 
hematocrit sample (often as part of a larger sample for hormones and 
catecholamines for another study). Following sampling, the catheter and stop 
cock were flushed with saline to prevent clotting.  Hematocrit was measured 
using the microcapillary centrifuge method with each sample examined in 
triplicate. After averaging, the hematocrit value for each time point was 
multiplied by 0.91 (“Fcell ratio”) to correct vein hematocrit to whole body 
hematocrit (Burge and Skinner 1995). 
4.9.12 URINE COLLECTION 
Urine output was monitored to support plasma volume data throughout bed-rest 
in conjunction with fluid intake.  Urine was collected throughout the testing 
period, starting with the first urination after wake-up (before the subject arrived 
in the laboratory) and ending with the final urine collection following the post-
LBNP test.  During HDBR tests urine was collected in the head-down position.  
Collected urine was weighed to monitor urine output throughout the testing 
period. Total urine output was calculated to assess differences in fluid balance 
(water excretion to the bladder) between 28h NFL HDBR and 28h FL HDBR. 
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4.9.13 WATER INTAKE 
As described in Section 4.8.3, water intake was controlled throughout the 
testing period.  These data were used to support plasma volume data throughout 
bed-rest in conjunction with urine collection.  Water intake included morning 
and evening hydrations (5 ml/kg), regulated water consumption between Hour 0 
- Hour 4 and Hour 24 - Hour 28 (determined from first test ± 25%), and ad 
libitum water intake during Hour 4 - Hour 24.  Water was accurately measured 
to the prescribed amount in a graduated water bottle before being given to the 
subject and noted in the test data sheet. If the subject was still thirsty, they were 
given up to 25% more water, and their additional consumption was noted. As a 
general observation, subjects often consumed the exact amount of water 
prescribed to them, but their thirst reflex varied between tests. Often subjects 
would either force themselves to consume the prescribed amount or remain 
thirsty, despite a consistent activity level and food intake across all tests. 
4.9.14 STATISTICS 
In order to study the hypotheses regarding the effects of 28h NFL HDBR on 
cardiovascular deconditioning, LBNP Pre and Post test data was be compared 
by a 2-way ANOVA (Pre/Post, LBNP), analyzed as mean ± standard error. Pre-
planned comparisons (Pre vs. Post response in the supine position, Pre vs. Post 
response at -40 mmHg, and 0 mmHg Post vs. -40 mmHg Post responses) were 
performed to clarify statistical differences, which were especially relevant in the 
event of a significant interaction effect between bed-rest and LBNP. Significant 
changes were defined as having p < 0.05. 
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Hypotheses regarding the efficacy of fluid loading on preventing 
cardiovascular deconditioning that arises following 28h NFL HDBR were 
studied by comparing LBNP testing data from 28h NFL HDBR Post and 28h 
FL HDBR Post tests. A 2-way ANOVA (NFL Post/FL Post, LBNP) were 
performed with significance determined as p<0.05. Pre-planned comparisons 
(NFL Post vs. FL Post response in the supine position and NFL Post vs. FL Post 
response at -40 mmHg) were also performed to clarify statistical differences, 
which were especially relevant in the event of a significant interaction effect 
between bed-rest and LBNP. A 2-way ANOVA comparing 28h NFL HDBR 
Pre and 28h FL HDBR Pre tests were also performed (FL Pre/NFL Pre, LBNP) 
to ensure there were no differences in baseline conditions. 
The 4-hour control models were used to isolate the effects of circadian 
rhythm, HDBR, and fluid loading on the 28h NFL HDBR and 28h FL HDBR 
tests. To isolate the effects of circadian rhythm, two statistical analyses were 
performed. A 2-way ANOVA comparing the Pre versus Post responses of the 4-
hour S NFL test (4SNFL Pre/4SNFL Post, LBNP) examined if there were any 
circadian effects in the seated position. This was followed by a second 2-way 
ANOVA comparing the 4-hour S NFL Post and 4-hour HDBR Post responses ( 
4h SNFL Post/4h HDBR Post, LBNP), which indicated if there was a circadian 
effect on bed-rest. If there were differences when comparing the S NFL Post 
and HDBR Post tests, the differences can be attributed to HDBR and not 
circadian rhythm. Only cardiovascular variables that were changed during 28h 
NFL HDBR and 28h FL HDBR were investigated by the control models. 
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To isolate the effects of fluid loading a single 2-way ANOVA was 
performed which compared the 4-hour S NFL Post and 4-hour S FL Post test 
responses (NFL Post/FL Post, LBNP). This test concluded whether or not the 
fluid loading protocol had an effect on blood volume in the absence of HDBR. 
Responses from the 4-hour S NFL Pre and 4-hour FL Pre tests were compared 
to ensure there were no differences in baseline conditions. 
To isolate the effects of HDBR, a single 2-way ANOVA was performed 
comparing 4-hour SFL Post and 28h FL HDBR Post test responses (4/28, 
LBNP). This test indicated if there were any effects of bed-rest on the fluid 
loading protocol. Responses from the 28h FL HDBR Pre and 4-hour SFL Pre 
tests were compared to ensure there are no differences in baseline conditions. 
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5 RESULTS 
5.1 EFFECT OF 28H HDBR ON CARDIOVASCULAR 
DECONDITIONING 
This analysis investigated the hypotheses regarding the effects of exposure to 
28 hours of 6° HDBR on the cardiovascular system. Specifically, it examined 
the degree of hypovolemia resulting from 28h NFL HDBR, as well as the 
hypothesized reductions in stroke volume and cardiac output, elevated TPR 
response, attenuated arterial and cardiopulmonary baroreflex responses, 
reductions in cardiac function, and reductions in splanchnic vasoconstrictor 
response. This analysis compared subjects' responses from Pre and Post LBNP 
testing. Relevant data are illustrated within the following section. Tables 
summarizing raw data (in the form of mean ± standard error), statistical 
analyses results, and sample sizes are included in Appendices A1, B and C 
respectively.  
5.1.1 HYPOVOLEMIA 
The 28h NFL HDBR protocol resulted in significant hypovolemia. Following 
28h HDBR, total blood volume was significantly reduced by 7%, from 5641.6  
ml ± 425.2 to 5246.5  ml ± 378.6 (p<0.05). Plasma volume fell by 11.5%, from 
3431.9 ml ± 271.7 to 3036.8 ml ± 225.1 (p<0.05). Figure 5.1-1 shows the 
changes in total blood volume and plasma volume throughout the 28h HDBR 
period.   From the graph, it can be seen that hypovolemia occurred within the 
early hours of bed-rest exposure. After 8 hours, total blood volume was reduced 
to 5027.3 ml ± 346.3, a reduction of 10.9%. Later time points (25.5, 26, 26.5, 
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27, and 27.5 hour time points) show that total blood and plasma volume 
remained diminished after 8 hours. 
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Figure 5.1-1: Total Blood Volume and Plasma Volume Trends Throughout 
28h NFL HDBR (n=8); TBV HDBR p<0.05, PV HDBR p<0.05 
Changes in hematocrit and weight also provided evidence of 
hypovolemia resulting from 28h NFL HDBR. Hematocrit was increased from 
39.61% ± 0.74 to 42.31% ± 0.63 across all 9 subjects (p<0.05). Subjects‟ 
weights decreased by 1.2 kg ± 0.5 following 28h NFL HDBR, reflecting the 
blood volume loss following bed-rest (p=0.04).  
5.1.2 BLOOD PRESSURE RESPONSE  
All subjects were able to successfully complete the LBNP before and after 28h 
HDBR. Mean arterial pressure (MAP) was maintained throughout LBNP 
testing following 28h HDBR. MAP was measured as 87.6 mmHg ± 1.6 in the 
supine position during pre testing and there were no significant effects of 
orthostatic stress (p=0.50) or bed-rest (p=0.95) on MAP.  Comparison of pre 
and post supine MAP (p=0.87) as well as pre and post MAP during maximal 
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orthostatic stress (p=0.63) indicated no changes with HDBR. However it must 
be noted that MAP did decrease significantly  between supine and maximum 
orthostatic stress during post testing, illustrating that blood pressure was not 
perfectly maintained during orthostatic stress following bed-rest exposure. 
Systolic blood pressure (SBP) was also unaffected by bed-rest (p=0.88). After 
HDBR, both supine SBP (p=0.65) and SBP during maximum stress (p=0.54) 
were not different from their respective pre values.  SBP was significantly 
reduced by increasing orthostatic stress (p<0.05). Diastolic blood pressure 
(DBP) was maintained constant between pre and post bed-rest testing (p=0.94) 
and with LBNP (p=0.17). Figure 5.1-2 illustrates the MAP, SBP, and DBP 
responses to orthostatic stress pre and post 28h HDBR.  
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Figure 5.1-2: MAP, SBP, and DBP Responses during LBNP Testing Pre 
and Post 28h NFL HDBR (n=9); MAP HDBR p=0.95, MAP LBNP p=0.50, 
SBP HDBR p=0.88, SBP LBNP p<0.05, DBP HDBR p=0.94, DBP LBNP 
p=0.17 
Pulse pressure (PP) was not altered by 28h HDBR (p=0.86), but was 
significantly reduced with increasing orthostatic stress (p<0.05). Comparison of 
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PP in the supine position before and after bed-rest yielded no differences 
(p=0.38). Similarly comparison of PP pre and post bed-rest at maximum 
orthostatic stress did not yield statistical differences (p=0.47). PP was 
significantly reduced during maximum orthostatic stress compared to the supine 
condition following 28h HDBR (p<0.05). The PP response is illustrated in 
Figure 5.1-3.  Pulse Pressure Response with 28-hour HDBR
LBNP (mmHg)


























Figure 5.1-3: PP Response during LBNP Testing Pre and Post 28h NFL 




5.1.3 HEART RATE RESPONSE 
Evidence of cardiovascular deconditioning was apparent following 28h HDBR 
when examining heart rate response. Subjects‟ overall heart rate responses post-
HDBR were not significantly different (p=0.22), but there was a significant 
interaction between bed-rest and orthostatic stress such that the elevation in 
heart rate post-HDBR became more apparent at higher levels of LBNP 
(p=0.01). The heart rate response is shown in Figure 5.1-4.  
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Figure 5.1-4: Heart Rate Response during LBNP Testing Pre and Post 28h 
HDBR (n=9); HDBR p=0.22, LBNP p<0.05, LBNP-HDBR interaction 
p<0.05 
Analysis of R-R interval showed a similar trend to heart rate, with R-R 
interval diminished at the higher levels of orthostatic stress post-HDBR 
compared to pre-HDBR (p<0.05).  
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5.1.4 ARTERIAL HEMODYNAMICS 
Analysis of stroke volume and cardiac output showed no cardiovascular 
deconditioning following exposure to 28h HDBR. The stroke volume response 
was unchanged with bed-rest (p= 0.29), and reduced with increasing orthostatic 
stress (p<0.05). Pre and post values of stroke volume are illustrated in Figure 
5.1-5.  Normalized Stroke Volume Response with 28-h HDBR
LBNP (mmHg)
































Figure 5.1-5: Normalized Stroke Volume Response during LBNP Testing 






The cardiac output resembled the stroke volume response. Cardiac 
output was not significantly affected by 28h HDBR (p=0.67), and was reduced 
with increasing orthostatic stress (p<0.05). The cardiac output response pre and 
post 28h HDBR is illustrated in Figure 5.1-6.  
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Figure 5.1-6: Normalized Cardiac Output Response during LBNP Testing 
Pre and Post 28h HDBR (n=9); HDBR p=0.67, LBNP p<0.05  
The total peripheral resistance (TPR) response was maintained 
following bed-rest. There were no statistical differences between TPR pre and 
post 28h NFL HDBR responses (p=0.87). TPR increased with orthostatic stress, 
increasing from 29.54 mmHg/(ml/[min*m
2
]) ± 2.00 to 35.50 
mmHg/(ml/[min*m
2
]) ± 2.84 during post bed-rest testing (p<0.05). The TPR 
response during orthostatic stress pre and post 28h NFL HDBR is illustrated in 
Figure 5.1-7.  
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Figure 5.1-7: Total Peripheral Resistance Response during LBNP Testing 
Pre and Post 28h HDBR (n=8); HDBR p=0.87, LBNP p<0.05 
Arterial compliance, calculated as normalized stroke volume divided by 
pulse pressure, was unchanged with 28h HDBR (p=0.24). Arterial compliance 
prior to 28h HDBR was 1.72 (ml/m
2
)/mmHg ± 0.25, which was not 
significantly different from the post 28h HDBR value of 1.22 (ml/m
2
)/mmHg ± 
0.18 (p<0.05).  
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5.1.5 VENOUS HEMODYNAMICS 
Venous hemodynamics showed evidence of cardiovascular deconditioning 
following exposure to 28h HDBR. Central venous pressure (CVP) was 
significantly reduced by bed-rest (p=0.01) and with orthostatic stress (p<0.05). 
CVP also exhibited an interaction between bed-rest and LBNP, as the reduction 
in CVP at higher levels of LBNP became more apparent post-HDBR (p<0.05). 
Figure 5.1-8 illustrates the CVP response pre and post 28h HDBR during 
orthostatic testing.  
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Figure 5.1-8: Central Venous Pressure Response during LBNP Testing Pre 







Unlike CVP, inferior vena cava (IVC) diameter was not significantly 
reduced after exposure to 28h NFL HDBR (p=0.19). However, IVC diameter 
was reduced with increasing orthostatic stress (p<0.05). The IVC diameter 
response pre and post 28h HDBR is illustrated in Figure 5.1-9.  
LBNP (mmHg)































Figure 5.1-9: Inferior Vena Cava during LBNP Testing Pre and Post 28h 
NFL HDBR (n=9); HDBR p=0.19, LBNP p<0.05 
Venous compliance data, calculated as delta IVC diameter divided by 
delta CVP (where delta values are measured as the value at 0 mmHg minus the 
value at -40 mmHg), did not show evidence of cardiovascular deconditioning 
after bed-rest. The venous compliance response during orthostatic testing pre 
and post 28h NFL HDBR is illustrated in Figure 5.1-10.  
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Figure 5.1-10: Venous Compliance Response during Pre and Post 28h NFL 
HDBR Testing (n=6); HDBR p=0.31) 
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5.1.6 SPLANCHNIC HEMODYNAMICS 
Splanchnic hemodynamics were affected by 28h NFL HDBR. Portal vein 
diameter was significantly diminished with bed-rest (p<0.05) and orthostatic 
stress (p<0.05), and there was a significant interaction between bed-rest and 
orthostatic stress where the reduction in portal diameter at higher levels of 
LBNP was more pronounced post-HDBR (p=0.04). This reduction in portal 
vein diameter with bed-rest indicates that splanchnic vasoconstriction increased 
with bed-rest. Figure 5.1-11 illustrates the portal vein diameter response during 
LBNP testing pre and post 28h bed-rest.  
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Figure 5.1-11: Portal Vein Diameter Response Pre Response during Pre 
and Post 28h NFL HDBR Testing (n=9); HDBR p<0.05, LBNP p<0.05 
Portal blood flow was significantly reduced following 28h NFL HDBR 
(p<0.05), reflecting an increase in splanchnic vascular resistance after bed-rest. 
These data are consistent with the portal diameter data described previously, 
suggesting an increase in splanchnic vascular resistance after bed-rest. 
However, portal blood flow was not reduced with increasing orthostatic stress 
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(p=0.28), as would be expected given the portal vein diameter data. Although 
the portal blood flow results may be physiological, the unexpected results are 
more likely attributed to measurement error, which is fully described in the 
“Limitations” section of this document. Figure 5.1-12 illustrates the portal vein 
blood flow response during LBNP testing pre and post 28h bed-rest.  
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Figure 5.1-12: Portal Vein Blood Flow Response during Pre and Post 28h 
NFL HDBR Testing (n=9); HDBR p<0.05, LBNP p=0.28 
Splanchnic impedance measurements indicated that there were no 
changes in blood volume in the splanchnic region between pre and post 28h 
HDBR, further evidence that splanchnic pooling did not occur following bed-
rest exposure. Splanchnic impedance was unchanged following 28h HDBR 
(p=0.37). Splanchnic impedance was increased with increasing orthostatic 
stress (p<0.05), illustrating that the splanchnic vasoconstriction seen in the 
portal vein diameter date led to a reduction of splanchnic blood volume during 
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orthostasis. The splanchnic impedance response during orthostatic testing pre 
and post 28h NFL HDBR is illustrated in Figure 5.1-13.  
LBNP (mmHg)
































Figure 5.1-13: Splanchnic Impedance Response Pre and Post 28h HDBR 
(n=8); HDBR p=0.37, LBNP p<0.05 
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5.1.7 LEFT VENTRICULAR PERFORMANCE 
Left ventricular performance was not affected by 28h HDBR. Ejection fraction 
was unchanged following exposure to 28h HDBR (p=0.19).  Ejection fraction 
was significantly reduced by orthostatic challenge, falling from 79.5% ± 1.1 to 
72.2% ± 1.4 during post orthostatic testing (p<0.05). The ejection fraction 
responses pre and post bed-rest at 0 and -40 mmHg are illustrated in Figure 5.1-
14.  
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Figure 5.1-14: Ejection Fraction Response following 28h HDBR (n=8); 
HDBR p=0.19, LBNP p<0.05 
Like ejection fraction, fractional shortening was also not affected by 28h 
HDBR (p=0.17), but was reduced during orthostatic challenge (p<0.05). 
Fractional shortening was reduced from 41.2% ± 1.0 to 34.9% ± 1.2 during post 
LBNP testing. Therefore bed-rest induced hypovolemia did not cause impaired 
left ventricular performance. Figure 5.1-15 illustrates the fractional shortening 
response pre and post bed-rest in both the supine position and during maximum 
orthostatic stress.  
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Figure 5.1-15: Fractional Shortening Response Pre and Post 28h HDBR 
(n=7); HDBR p=0.17, LBNP p<0.05 
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5.1.8 ARTERIAL BAROREFLEX 
Transfer function analysis was performed on the SBP and R-R Interval data of 7 
of the 9 subjects. The remaining 2 subjects had nonstationary datasets with 
rapid R-R Interval peaks. The software analyzed these peaks as a discontinuity 
in the data signal, or a nonlinearity, which is a violation of the criterion required 
to perform transfer function analysis, and prevented the analysis to be 
performed. Figure 5.1-16 illustrates an example of a “discontinuity” in a RR-
Interval dataset which prevented analysis. 
 
Figure 5.1-16: Discontinuity in an Individual Subject’s R-R Interval Signal 
SBP datasets were linearly interpolated where “Physiocal” had been 
performed by the Finometer, in order to obtain longer datasets. The 
noninterpolated datasets were also analyzed and compared to the interpolated 
datasets, with no significant difference in coherence values between the two 
methods of analysis. Since the noninterpolated datasets could be up to 80 data 
points shorter, the interpolated data were used to provide more data points for 
the analysis. Figures 5.1-17, 5.1-18, and 5.1-19 illustrate an individual‟s raw 
arterial SBP and RR-interval data signals sampled in the supine position, the 
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signals‟ autospectra (pxx and pyy), and transfer function analysis results of gain 
(pxy and txy), phase (phi) and coherence (cxy) respectively. 
 




Figure 5.1-18: Autospectra of SBP (pxx) and R-R Interval (pyy) Signals for 
an Individual Subject 
 
Figure 5.1-19: Gain (pxy), Normalized Gain (txy), Coherence (cxy), and 



























Twenty-eight hour bed-rest did impact arterial baroreflex sensitivity. 
There were no significant differences in MF gain with 28h HDBR (p=0.88), 
which was determined in the frequency range from 0.05-0.15 Hz when 
coherence was greater than 0.5. This illustrated that the sympathovagal balance 
of arterial blood pressure modulation had not changed with bed-rest exposure. 
Similarly, there were no significant differences in HF gain following 28h 
HDBR (p=0.37), which was determined in the frequency range of 0.15-0.40 Hz. 
These data illustrate there were no changes in cardiac vagal modulation.  
Figures 5.1-20 and 5.1-21 illustrate the MF and HF gain responses pre and post 
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Figure 5.1-20: Mid-Frequency Gain Response during LBNP Testing Pre 

























P re  
P os t 
Figure 5.1-21: High-frequency Gain Response during LBNP Testing Pre 
and Post 28h NFL HDBR (n=7); HDBR p=0.37, LBNP p<0.05 
Analysis of MF and HF phase responses also illustrated that arterial 
baroreflex sensitivity was not changed with 28h HDBR. There were no 
significant changes in MF phase (p=0.45) or HF phase (p=0.09) between pre 
and post 28h bed-rest data. This illustrated that the R-R interval time response 
to changes in SBP was not faster or slower as a result of bed-rest exposure. 
Figures 5.1-22 and 5.1-23 illustrate the MF and HF phase responses pre and 
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Figure 5.1-22: Mid-frequency Phase Response during LBNP Testing Pre 
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Figure 5.1-23: High-frequency Phase Response during LBNP Testing Pre 
and Post 28h NFL HDBR (n=7); HDBR p=0.09, LBNP p<0.05 
There was a significant effect of orthostatic stress on arterial baroreflex 
sensitivity with orthostatic stress. Arterial baroreflex sensitivity decreased with 
increasing orthostatic stress with reductions in the response magnitude of both 
MF gain (p<0.05) and HF gain (p<0.05), as well as increased time delay shown 
as an increased negative HF phase response (p<0.05).  
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It must be noted that coherence was less than 0.5 in the HF region 
during -20 and -40 mmHg (data available in Appendix A1), perhaps due to a 
low signal to noise ratio. At -20 mmHg, 3 subjects had coherence less than 0.5 
in the HF region during pre testing, and 4 subjects during post testing. At -40 
mmHg, all of the 7 subjects had coherence less than 0.5 in the HF region during 
pre testing, and 4 subjects during post testing. 
5.1.9 CARDIOPULMONARY BAROREFLEX 
The cardiopulmonary baroreflex was analyzed by measuring brachial blood 
flow velocity and brachial diameter, and using these variables to compute 
brachial blood flow. Analysis of brachial blood flow velocity showed a 
reduction with increasing LBNP (p<0.05), which is expected and mirrors the 
systemic vascular resistance response to increasing orthostatic stress discussed 
earlier. The brachial blood flow velocity response to orthostatic stress is 
illustrated in Figure 5.1-24. Conversely, analysis of brachial blood flow 
indicated that this variable was maintained constant throughout orthostatic 
stress (p=0.65), as illustrated in Figure 5.1-25. Brachial blood flow is expected 
to show a similar reduction with increasing stress as seen in brachial blood flow 
velocity. Brachial diameter is included in the calculation of brachial blood flow, 
and may be a source of error in brachial blood flow calculations at levels of 
LBNP above 0 mmHg since brachial diameter was only measured in the supine 
position. Therefore, measurements of brachial blood flow during orthostatic 
stress should be discarded. However the decrease in brachial blood flow 
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velocity provides an indication that the cardiopulmonary baroreflex is causing 
forearm vasoconstriction during increasing LBNP. 
These data also indicate that cardiopulmonary baroreflex function was 
unchanged after 28h NFL HDBR. Comparing supine values pre and post bed-
rest, brachial blood flow velocity (p=0.11), brachial blood flow (p=0.06), and 
brachial diameter (p=0.72) were unchanged in the supine position. Therefore 
the cardiopulmonary baroreflex is performing at the same baseline flow 
following 28h NFL HDBR; there is no attenuation of the cardiopulmonary 
baroreflex following 28h NFL HDBR. The brachial blood flow velocity, 
brachial blood flow, and brachial diameter responses following bed-rest are 
illustrated in Figures 5.1-24, 5.1-25, and 5.1-26 respectively. 
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Figure 5.1-24: Brachial Blood Flow Velocity Response during LBNP 






































Figure 5.1-25: Brachial Blood Flow Response during LBNP Testing Pre 
and Post 28h NFL HDBR (n=8); HDBR p=0.09, LBNP p<0.65 























Figure 5.1-26: Diameter Response during LBNP Testing Pre and Post 28h 
NFL HDBR (n=9); HDBR p=0.72 
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5.1.10 SUMMARY OF 28H HDBR EFFECTS ON CARDIOVASCULAR 
DECONDITIONING 
Contrary to the hypotheses, no subjects experienced orthostatic hypotension 
following 28h bed-rest, and there was no evidence of loss of blood pressure 
maintenance following 28h HDBR.  Examination of MAP, SBP, DBP, and PP 
showed that these cardiovascular variables were unchanged with bed-rest. 
Although SBP and PP were reduced with increasing orthostatic stress, they did 
not limit overall MAP maintenance after exposure to bed-rest. 
 As hypothesized, hypovolemia resulted from exposure to 28h NFL 
HDBR. This was illustrated by significant falls in total blood volume and 
plasma volume and increases in hematocrit, as well as indirectly from a 
reduction in weight. 
 Following bed-rest, the heart rate response to orthostatic stress was 
significantly elevated, which was also in line with the hypotheses. However, 
stroke volume and cardiac output were not significantly affected by bed-rest, 
though both variables diminished with orthostatic stress. TPR was also 
unaffected by bed-rest, which was contrary to the hypothesis, as the 
vasoconstriction response increased similarly during orthostatic stress before 
and after bed-rest.  
CVP was significantly reduced following bed-rest, as expected, and IVC 
diameter tended to diminish as well indicating the impact of hypovolemia 
(reduction was not significant). However there was no evidence of the 
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hypothesized venous pooling, as central venous compliance was unchanged by 
28h HDBR.  
Splanchnic hemodynamics were altered by 28h bed-rest, however not as 
expected. Portal vein diameter was reduced after bed-rest exposure, and 
reduced further during orthostatic stress. Portal blood flow was also reduced 
following bed-rest, supporting the finding of increased splanchnic 
vasoconstriction following bed-rest. However portal blood flow was not 
reduced with orthostatic stress, casting suspicion on the validity of this 
measurement. Splanchnic impedance was not affected by bed-rest, illustrating 
that there was not a significant change in blood volume in the splanchnic 
vasculature due to bed-rest exposure. There was no evidence of the 
hypothesized splanchnic pooling after 28h HDBR. 
The hypothesized reduction of left ventricular function did not arise 
following 28h NFL HDBR, rather it was maintained. Ejection fraction and 
fractional shortening were not affected by bed-rest with responses in the supine 
and during maximum orthostatic stress unchanged between pre and post testing.  
Arterial baroreflex sensitivity was also unaffected by 28h NFL HDBR, 
which was not in accordance with the hypothesized result. There were no 
significant differences in magnitude or time delay responses in the mid-
frequency and high-frequency regions. This information is evidence that there 
are no changes in vagal or sympathetic modulation of heart rate response due to 
short-term hypovolemia. 
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Cardiopulmonary baroreflex was also unchanged by exposure to 28h 
NFL HDBR. Supine brachial diameter, brachial blood flow velocity, and 
brachial blood flow were unchanged following bed-rest. 
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5.2 EFFICACY OF FLUID LOADING PROTOCOL 
This analysis investigated the hypotheses that the hypovolemia and 
cardiovascular deconditioning resulting from 28h NFL HDBR are restored by 
the fluid loading protocol. Subjects completed a 28h HDBR protocol similar to 
that used to investigate the effects of bed-rest alone (described in Section 5.1), 
with the fluid loading protocol performed between 25.5 and 27.5 hour time 
points. This section compares the subjects' responses during NFL HDBR and 
FL HDBR Post LBNP testing to determine the effects of the fluid loading 
protocol. Tables summarizing raw data (in the form of mean ± standard error), 
statistical analyses results, and sample sizes are included in Appendices A2, B 
and C respectively.  Pre data from the 28h NFL HDBR and 28h FL HDBR were 
also compared to ensure there were no statistical differences in baseline testing 
for the two models; the statistical results of these tests can also be found in 
Appendix B.  
5.2.1 SUBJECTS’ RESPONSE TO FLUID LOADING PROTOCOL 
During the fluid loading protocol, 4 of the 9 subjects experienced symptoms of 
nausea. Two subjects could not complete their prescription of NaCl and water 
due to the nausea, and two subjects (1 of whom did not complete the fluid 
loading protocol) vomited prior to post bed-rest orthostatic testing. Vomiting 
reduced the efficacy of the fluid loading protocol by reducing ingested fluid 
volume and causing additional discomfort and nausea. The data of the two 
subjects who did not complete the fluid loading protocol are not included in the 
following comparison of NFL and FL post tests. Table 5.2-1 summarizes fluid 
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loading protocol data for each subject. Subjects who did not complete fluid 
loading are highlighted.  
 Table 5.2-1: Summary of Subjects' Fluid Loading Data during 28h FL 
HDBR 
 
5.2.2  EFFECT OF FLUID LOADING ON PREVENTING HYPOVOLEMIA 
Comparing the overall changes in blood volume that occurred during fluid-
loading and non-fluid loading tests showed that fluid loading was not successful 
in restoring hypovolemia resulting from 28h NFL HDBR. After 28h FL HDBR, 
total blood volume was reduced by 380.1 ml ± 74.3, which was similar to the 
amount of total blood volume lost during 28h NFL HDBR, 390.3 ml ± 66.8 
(p=0.29). Plasma volume was reduced similarly, with no significant differences 
between NFL Post and FL Post tests (p=0.22). Figure 5.2-1 shows the total 






















1 8.8 1102.5 8.8 1102.5 100 No No 
2 8.5 1057.5 8.5 1057.5 100 No No 
3 8.7 1084 8.7 1084 100 No No 
4 9.1 1143 9.1 1143 100 No No 
5 9.3 1167 9.3 1167 100 Yes No 
6 9.3 1167 8.2 1125 96 Yes Yes 
7 7.4 922 2.9 500 54 Yes No 
8 9.8 1225.5 9.8 1225.5 100 Yes Yes 




























Figure 5.2-1: Total Blood Volume Changes during 28h FL HDBR and 28h 
NFL HDBR (data points for FL and NFL include only subjects who 
completed FL protocol, n=6); Post FL/NFL HDBR p=0.29 
However, examination of the fluid loading period showed that fluid 
loading did affect total blood and plasma volume. The open circles in Figure 
5.2-1 illustrate the total blood volume response during the 28h FL HDBR test. It 
can be seen that after the 25.5h time point (the start of the fluid loading period), 
total blood volume progressively increased until the final 28h time point. 
However, total blood volume was not yet restored to its initial pre bed-rest 
value. If fluid loading protocol had been started earlier, fluid restoration may 
have been successful. 
The difference in total blood volume at the 8h time point between FL 
and NFL tests is noted, and may be due to unregulated fluid intake between 
hour 4 and hour 24. The reader is also reminded that subjects who did not finish 
the fluid loading protocol were removed from this analysis, which accounts for 
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the differences in 28h NFL blood volume data described in Sections 5.1 and 
5.2. 
Failure to restore blood volume was also apparent by analysis of 
hematocrit over the course of 28h FL HDBR testing. Hematocrit was increased 
by 2.60% ± 0.34 at the completion of the 28h FL HDBR protocol, which was 
similar to the increase of 3.04% ± 0.68 seen after the 28h NFL HDBR protocol 
(p=0.18). Weight change between pre and post testing also indicated that fluid 
volume loss was sustained despite fluid loading. Weight loss was 1.1 kg ± 0.3 
following 28h FL HDBR, compared with a loss of 1.0 kg ± 0.6 following 28h 
NFL HDBR (p=0.98). 
5.2.3 EFFECT OF FLUID LOADING PROTOCOL ON BLOOD 
PRESSURE RESPONSE 
After 28h FL HDBR all subjects successfully completed the progressive LBNP 
test except for one subject who experienced a presyncopal drop in blood 
pressure. This subject had an adverse reaction to the fluid loading protocol, 
experienced extreme nausea to the point of vomiting, and did not complete the 
prescribed salt and water intake of the fluid loading protocol.  The subject was a 
strong finisher in each of the other four testing models (and 9 LBNP tests), and 
it was not his first time participating in orthostatic testing. His presyncopal 
symptoms may be attributed to vomiting and feeling of malaise following the 
fluid loading protocol. Data from this subject, as well as the second subject that 
did not complete the fluid loading protocol, were removed from analysis of the 
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fluid loading protocol‟s efficacy; only subjects that completed fluid loading 
were analyzed (n=7). 
Blood pressure during post bed-rest testing was not affected by fluid 
loading. There were no significant differences between the 28h NFL Post and 
28h FL Post tests concerning MAP (p=0.35), SBP (p=0.35), DBP (p=0.43), and 
PP responses (0.41). Figure 5.2-2 illustrates that MAP and DBP responses 
remained constant and SBP fell similarly during orthostatic testing after 28h FL 
HDBR and 28h NFL HDBR testing. Figure 5.2-3 illustrates the PP 
response.
L B N P  (m m H g )


























1 6 0 M A P  N F L  P os t 
M A P  F L  P os t 
S B P  N F L  P os t 
S B P  F L  P os t 
D B P  N F L  P os t 
D B P  F L  P os t 
Figure 5.2-2: MAP, SBP, and DBP Responses during LBNP Testing 
following 28h FL HDBR and 28h NFL HDBR (data points for FL and NFL 
include only subjects who completed FL protocol n=7); MAP Post FL/NFL 
HDBR p=0.35, SBP Post FL/NFL HDBR p=0.35, DBP Post FL/NFL HDBR 
p=0.43 
 86 
L B N P  (m m H g )




















N F L  P os t 
F L  P os t 
Figure 5.2-3: Pulse Pressure Response during LBNP Testing following 28h 
FL HDBR and 28h NFL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=7); Post FL/NFL HDBR p=0.40 
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5.2.4 EFFECT OF FLUID LOADING PROTOCOL ON HEART RATE 
RESPONSE 
Analysis of heart rate confirmed that the fluid loading protocol did not prevent 
cardiovascular deconditioning. Heart rate was increased to a similar extent 
during LBNP testing following 28h FL HDBR as it was after 28h NFL HDBR 
(p=0.34). Analysis of R-R interval also showed there was no significant 
difference between the FL and NFL Post responses (p=0.43). The heart rate 
responses during orthostatic testing following 28h FL HDBR and 28h NFL 
HDBR are illustrated in Figure 5.2-4.  
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Figure 5.2-4: Heart Rate Response during LBNP Testing following 28h FL 
HDBR and 28h NFL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=7); Post FL/NFL HDBR p=0.34 
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5.2.5 EFFECT OF FLUID LOADING PROTOCOL ON THE ARTERIAL 
HEMODYNAMICS RESPONSE 
Arterial hemodynamic responses were not affected by fluid loading. Stroke 
volume tended to be higher following 28h FL HBBR compared to 28h NFL 
HDBR however this effect was not significant (p=0.07). Although there was an 
interaction effect of LBNP and the fluid loading treatment (p<0.05), 
comparison of stroke volume responses in the supine position (p=0.19) and at 
maximum orthostatic stress (p=0.34) showed no significant differences between 
FL and NFL post testing. Figure 5.2-5 illustrates the stroke volume response to 
LBNP following 28h FL HDBR, with the 28h FL HDBR Post response 
included for comparison.  
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Figure 5.2-5: Stroke Volume Response during LBNP Testing following 28h 
FL HDBR and 28h NFL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=7); Post FL/NFL HDBR p=0.07, 
Post FL/NFL HDBR-LBNP interaction p<0.05 
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Like stroke volume, the cardiac output response following 28h HDBR 
was not affected by fluid loading. There was no statistical difference between 
the cardiac output response following 28h FL HDBR and 28h NFL HDBR 
(p=0.32). Like stroke volume, there was an interaction between LBNP and the 
fluid loading treatment (p=0.01), however there were no significant differences 
in the 28h FL HDBR Post and 28h NFL HDBR Post cardiac output responses in 
the supine position (p=0.13) or during maximum orthostatic stress (p=0.98). 
The cardiac output responses during post LBNP testing following 28h NFL 
HDBR and 28h FL HDBR are illustrated in Figure 5.2-6.  
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Figure 5.2-6: Cardiac Output Response during LBNP Testing following 
28h FL HDBR and 28h NFL HDBR (data points for FL and NFL include 
only subjects who completed FL protocol, n=7); Post FL/NFL HDBR 
p=0.32, Post FL/NFL HDBR-LBNP interaction p<0.05 
Fluid loading did not affect the systemic vasoconstriction response 
following 28h HDBR. There were no significant differences between the TPR 
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responses during LBNP testing following 28h FL HDBR and 28h NFL HDBR 
(p=0.50), as seen in Figure 5.2-7.  
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Figure 5.2-7: Total Peripheral Resistance Response during LBNP Testing 
following 28h FL HDBR and 28h NFL HDBR (data points for FL and NFL 
include only subjects who completed FL protocol, n=5); Post FL/NFL 
HDBR p=0.50 
 Arterial compliance was also unaffected by the fluid loading protocol. 
There was no significant difference between the arterial compliance following 
28h FL HDBR and 28h NFL HDBR (p=0.16). Arterial compliance after 28h FL 
HDBR was 1.48 (ml/m
2
)/mmHg ± 0.14, which did not significantly differ from 





5.2.6 EFFECT OF FLUID LOADING PROTOCOL ON VENOUS 
HEMODYNAMICS 
There was no significant difference between the CVP responses 
following 28h FL HDBR and 28h NFL HDBR (p=0.44), illustrating that blood 
return to the heart remained diminished following bed-rest despite the 
countermeasure. However, CVP was increased following 28h FL HDBR 
compared to the response following 28h NFL HDBR. This result should be 
considered since the sample size was small (n=5), and since there was a slow 
increase in total blood volume throughout the fluid loading period. Stroke 
volume was also elevated (not significantly) after fluid loading, which is 
consistent with increased CVP. If the fluid loading period was longer, CVP may 
have been elevated following 28h FL HDBR compared to NFL testing. . The 
CVP responses during post LBNP testing following 28h NFL HDBR and 28h 
FL HDBR are illustrated in Figure 5.2-8.  
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Figure 5.2-8: Central Venous Pressure Response during LBNP Testing 
following 28h FL HDBR and 28h NFL HDBR (data points for FL and NFL 
include only subjects who completed FL protocol, n=5); Post FL/NFL 
HDBR p=0.44 
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Analysis of IVC diameter responses further supported the findings that 
CVP remained diminished despite fluid loading. There were no significant 
differences between the 28h FL HDBR and 28h NFL HDBR post responses to 
LBNP (p=0.50). IVC diameter remained diminished following 28h FL HDBR, 
as illustrated in Figure 5.2-9.  
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Figure 5.2-9: Inferior Vena Cava Diameter Response during LBNP Testing 
following 28h FL HDBR and 28h NFL HDBR (data points for FL and NFL 
include only subjects who completed FL protocol, n=7); Post FL/NFL 
HDBR p=0.50 
Venous compliance was also not affected by fluid loading, as there were 
no differences in the venous compliance response between the 28h FL HDBR 
and 28h NFL post testing (p=0.81), as illustrated in Figure 5.2-10. 
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Figure 5.2-10:  Venous Compliance Response following 28h FL HDBR and 
28h NFL HDBR (data points for FL and NFL include only subjects who 
completed FL protocol, n=6); Post FL/NFL HDBR p=0.81 
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5.2.7 EFFECT OF FLUID LOADING ON SPLANCHNIC 
HEMODYNAMICS 
Splanchnic hemodynamics were unaffected by fluid loading. Portal vein 
diameter remained diminished following 28h FL HDBR despite ingested salt 
and water. There was no significant difference in portal vein diameter between 
28 FL HDBR and 28 FL HDBR post tests (p=0.27), as illustrated in 5.2-11.  
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Figure 5.2-11: Portal Vein Diameter Response during LBNP Testing 
following 28h FL HDBR and 28h NFL HDBR (data points for FL and NFL 
include only subjects who completed FL protocol, n=7); Post FL/NFL 
HDBR p=0.27 
Splanchnic impedance was not significantly altered by the fluid loading 
protocol. There was no difference in the splanchnic impedance response 
following 28h FL HDBR and 28h NFL HDBR (p=0.23), as illustrated by Figure 
5.2-12.  
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Figure 5.2-12: Splanchnic Impedance Response during LBNP Testing 
following 28h FL HDBR and 28h NFL HDBR (data points for FL and NFL 
include only subjects who completed FL protocol, n=6); Post FL/NFL 
HDBR p=0.23 
 96 
5.2.8 EFFECT OF FLUID LOADING ON LEFT VENTRICULAR 
PERFORMANCE 
Left ventricular performance was not affected by 28h NFL HDBR, and this 
response was unchanged with fluid loading.  There was no significant 
difference in ejection fraction responses between 28h FL HDBR and 28h NFL 
HDBR post tests (p=0.71), as illustrated in Figure 5.2-13. 
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                           Figure 5.2-13: Ejection Fraction Response during LBNP 
Testing following 28h FL HDBR and 28h NFL HDBR (data points for FL 
and NFL include only subjects who completed FL protocol, n=6); Post 
FL/NFL HDBR p=0.71 
Similarly, there were no changes in fractional shortening between the 
28h FL HDBR and 28h NFL HDBR post tests (p=0.78), as illustrated in Figure 
5.2-14.  
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Figure 5.2-14: Fractional Shortening Response during LBNP Testing 
following 28h FL HDBR and 28h NFL HDBR (data points for FL and NFL 
include only subjects who completed FL protocol, n=6); Post FL/NFL 
HDBR p=0.78 
5.2.9 EFFECT OF FLUID LOADING ON ARTERIAL BAROREFLEX 
RESPONSE 
The arterial baroreflex analysis comparing 28h FL HDBR and 28h NFL HDBR 
was performed with 5 subjects. Two subjects were removed since they did not 
complete the fluid loading protocol and two were removed for discontinuities in 
their SBP signal, as described in Section 5.1.9. 
There were no differences in arterial baroreflex response responses 
between 28h FL HDBR and 28h NFL HDBR. MF gain responses were not 
statistically different between NFL and FL post orthostatic testing (p=0.13), nor 
did HF gain responses differ (p=0.94). The MF gain and HF gain responses 
during post LBNP testing following 28h NFL HDBR and 28h FL HDBR are 
illustrated in Figures 5.2-15 and 5.2-16.  
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Figure 5.2-15: MF Gain Response during LBNP Testing following 28h FL 
HDBR and 28h NFL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=5); Post FL/NFL HDBR p=0.13 
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Figure 5.2-16: HF Gain Response during LBNP Testing following 28h FL 
HDBR and 28h NFL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=5); Post FL/NFL HDBR p=0.94 
There were also no significant differences in the time course of the 
response. MF phase did not differ between 28h NFL HDBR and 28h FL HDBR 
post orthostatic testing (p=0.97), nor did HF phase differ (p=0.73). The MF 
phase and HF phase responses during post LBNP testing following 28h NFL 
HDBR and 28h FL HDBR are illustrated in Figures 5.2-17 and 5.2-18. 
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Figure 5.2-17: MF Phase Response during LBNP Testing following 28h FL 
HDBR and 28h NFL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=5); Post FL/NFL HDBR p=0.98 
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Figure 5.2-18: Phase Response during LBNP Testing following 28h FL 
HDBR and 28h NFL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=5); Post FL/NFL HDBR p=0.73 
It must be noted that as seen during 28h NFL HDBR testing, coherence 
was on average less than 0.5 in the HF region during -20 and -40 mmHg during 
28h FL HDBR, perhaps due to a low signal to noise ratio. Coherence was below 
0.5 in 2 of the 5 subjects at -20 mmHg, and in 3 of the 5 subjects at -20 mmHg 
in the 28h FL HDBR test. 
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5.2.10 EFFECT OF FLUID LOADING ON CARDIOPULMONARY 
BAROREFLEX RESPONSE 
Fluid loading, like bed-rest, had no significant impact on cardiopulmonary 
baroreflex. There were no significant changes in brachial diameter (p=0.66), 
brachial blood flow velocity (p=0.74), or brachial blood flow (p=0.94) in the 
supine position following 28h FL HDBR compared to 28h NFL HDBR. This 
indicates that fluid loading did not alter cardiopulmonary baroreflex function 
following 28h bed-rest. The brachial blood flow velocity, brachial blood flow, 
and brachial diameter responses following 28h FL HDBR are illustrated in 
Figures 5.2-19, 5.2-20, and 5.2-21 respectively.  
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Figure 5.2-19: Brachial Blood Flow Velocity Response following 28h NFL 
HDBR and 28h FL HDBR (data points for FL and NFL include only 
subjects who completed FL protocol, n=5); Post FL/NFL HDBR p=0.94 
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Figure 5.2-20: Brachial Blood Flow Response following 28h NFL HDBR 
and 28h FL HDBR (data points for FL and NFL include only subjects who 
completed FL protocol, n=5); Post FL/NFL HDBR p=0.74 






















Figure 5.2-21: Brachial Diameter Response following 28h NFL HDBR and 
28h FL HDBR (data points for FL and NFL include only subjects who 
completed FL protocol, n=7); Post FL/NFL HDBR p=0.66 
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5.2.11 FLUID REDISTRIBUTION WITH FLUID LOADING PROTOCOL 
It is apparent that water ingested during the fluid loading protocol was either 
not absorbed or did not remain in the vasculature for a substantial period of 
time since blood volume was not significantly increased or fully restored to its 
pre 28h HDBR values following the fluid loading protocol. Instead, the fluid 
may have been absorbed into the extravascular space, excreted by the kidneys, 
or it may have remained in the stomach for the duration of the bed-rest period. 
This study was not designed to analyze fluid distribution, however some data 
may provide a rough indication. 
 As described earlier, 4 of the 9 subjects became nauseated during the 
fluid loading protocol. They were lying in the 6° head-down position, so 
ingested fluid and salt would tend towards the upper part of the stomach by the 
esophagus. This may have been the source of the nausea. Some subjects had the 
feeling of nausea up until commencement of orthostatic testing, suggesting that 
some of the ingested fluid remained in the stomach. This hypothesis is 
supported by the slow steady increase in total blood volume and plasma volume 
seen during the fluid loading period. The progressive increase was not fast 
enough to restore blood volume during the 2.5h fluid loading period, therefore 
fluid may have remained in the stomach at the end of the fluid loading period.  
A comparison of fluid intake and output during 28h NFL HDBR and 
28h FL HDBR provides insight into water redistribution. Fluid intake greatly 
differed between the two bed-rest protocols. During 28h NFL HDBR subjects 
ingested 3155.44 ml ± 343.65, whereas subjects ingested 4349.43 ml ± 347.54 
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during the fluid loading protocol (p<0.05), the difference due to the prescribed 
water in the fluid load as well as water ingested at libitum between hour 8 and 
bed-time during the 28h bed-rest period. Urinary output was not significantly 
different between the two tests. Urine excretion throughout 28h NFL HDBR 
was 4139.63 ml ± 611.89, during the 28h FL HDBR test urine excretion was 
4668.18 ml ± 406.81 (p=0.14). These data suggest that the fluid ingested during 
the fluid loading protocol was not absorbed by the kidneys, and supports the 
hypothesis stated above that some subjects experienced delayed absorption of 
fluid during the fluid loading protocol. The elevated urinary excretion during 
the 28h FL test, though not significantly different from the 28h NFL urinary 
excretion, also supports the idea that some subjects experienced increased fluid 
excretion during 28h FL HDBR. It is possible that the fluid loading protocol 
was not very effective because ingested fluid was quickly compensated for to 
keep fluid levels at the new baseline created by HDBR. Table 5.2-2 illustrates 
fluid intake and urine output data for NFL and FL tests. 
Table 5.2-2: Average Fluid Intake and Urinary Excretion during 28h NFL 
HDBR and 28h FL HDBR Tests (n=9) 
Test 
Total Fluid Intake 
including Fluid Load 
(ml) 
Water Intake during 





3155.44 ± 343.65 0 4139.63 ± 611.89 
28h FL   
HDBR 
4349.43 ± 347.65 1067.33 ± 73.17 4668.18 ± 406.81 
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5.2.12 EFFECT OF FLUID AND SALT INTAKE ON NAUSEA AND 
ORTHOSTATIC TEST COMPLETION 
Successful completion of LBNP testing was independent of fluid intake during 
the 28h HDBR period. Individual fluid intake (excluding prescribed water 
intake for the fluid loading protocol) ranged from 2010 ml to 5544 ml across 
each 28h NFL HDBR and 28h FL HDBR test. The variation in subjects‟ 
individual intake between FL and NFL tests was due to ad libitum water intake 
between hour 4 and bed-time. Fluid intake for each subject during both 28h 
NFL HDBR and 28h FL HDBR testing is summarized in Table 5.2-3. There 
was only one case of syncope that occurred following 28h FL HDBR, which is 
indicated by the asterisk in the table.  Figure 5.2-22 plots total fluid intake 
(including prescribed water during fluid loading) versus orthostatic test 
completion. Test completion does not appear to be affected by fluid intake 
during the 28 hour bed-rest period as the lone case where presyncopal 
symptoms caused orthostatic testing to be terminated early was a test where the 
subject ingested an average amount of water compared to all other tests. 
Table 5.2-3: Fluid Volume Intake during 28h NFL HDBR and 28h FL 
HDBR Tests (Water Prescribed for Fluid Load in brackets) 
 Fluid Intake (ml) 
Subject 28h NFL HDBR 28h FL HDBR (+ FL) 
1 3609 4915.5 (+ 1102.5) 
2 2388 1955 (+ 1057.5) 
3 2525 2820 (+ 1084) 
4 2755 2720 (+ 1143) 
5 3480 2735 (+ 1167) 
6* 3006 3252 (+ 1125) 
7 2010 3073 (+ 500) 
8 3082 3223 (+ 1225.5) 
9 5544 4845.5 (+ 1201.5) 
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Figure 5.2-22: Effect of Fluid Volume Intake (including prescribed intake 
for fluid load) on Onset of Syncope following 28h FL HDBR and 28h NFL 
HDBR (n=9) 
Fluid intake was not the cause for the onset of nausea and vomiting 
during 28h FL HDBR. Figure 5.2-23 plots total fluid intake versus nausea/no 
nausea, and it is apparent that subjects who experienced nausea were not the 
subjects who ingested high amounts of water, nor were they the subjects who 
ingested small amounts of water throughout 28h FL HDBR. Rather, nausea 
only occurred following the fluid loading protocol. 
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Figure 5.2-23: Effect of Fluid Intake on Nausea (n=9) 
Onset of nausea following fluid loading seems to be subject specific 
rather than related to a high prescribed salt intake during the protocol. Figure 
5.2-24 plots the prescribed salt intake of each subject during fluid loading 
versus nausea/no nausea and highlights subjects who did not complete the fluid 
loading protocol. Subjects who experienced nausea represented a broad 
spectrum of prescribed salt intake, from the highest (9.8g) to the lowest (7.4g) 
quantities. Therefore factors other than, or in addition to quantity of salt, played 
a role in onset of nausea following fluid loading. 
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Figure 5.2-24: Effect of Prescribed Salt Intake during Fluid Loading on 
Nausea and Protocol Completion (n=9)
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5.2.13 SUMMARY OF EFFICACY OF FLUID LOADING PROTOCOL 
Contrary to the hypothesis, fluid loading was unsuccessful at restoring blood 
volume lost during 28h HDBR. Total blood volume, plasma volume and 
hematocrit were not significantly changed following 28h FL HDBR compared 
to their responses following 28h NFL HDBR. These data show that total blood 
volume and plasma volume were not fully restored by the fluid loading protocol 
after 28h HDBR.  
A closer examination of changes in total blood volume during the fluid 
loading period showed that total blood volume progressively increased, 
illustrating that the fluid loading protocol had the desired effect, but was given 
insufficient time to restore normovolemia. Plasma volume increased similarly 
during the fluid load. The volume of the prescribed fluid was not yet absorbed 
into the vasculature after 2.5 hours. It was also noted that the volume of 
excreted urine was larger (though not significantly) during 28h FL HDBR 
compared to 28h NFL HDBR, indicating that fluid ingested during the fluid 
loading protocol was compensated for to keep fluid levels at the new baseline 
established by HDBR. It should also be reiterated that the sample size of the 
fluid loading analysis was reduced compared to the analysis of 28h NFL pre 
versus post testing. 
Fluid loading was not fully successful at preventing the cardiovascular 
deconditioning that resulted from 28h HDBR. Heart rate responses remained 
increased following 28h HDBR with fluid loading, although they were lower 
than post NFL HDBR values. There were no significant changes in stroke 
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volume, cardiac output, TPR, or arterial compliance with fluid loading, 
although stroke volume did show an elevated response. Central venous pressure 
and inferior vena cava diameter were statistically unchanged compared the NFL 
Post test; however CVP did exhibit a non-significant elevation following fluid 
loading. The small sample size could have played a role in the statistical 
analysis of 28h FL HDBR versus 28h NFL HDBR post tests. 
 Splanchnic hemodynamics were not altered by fluid loading. Portal 
vein diameter remained reduced following 28h FL HDBR, indicating the 
splanchnic resistance remained increased following fluid loading compared to 
baseline. Splanchnic impedance was also not affected by fluid loading, and was 
unchanged compared to baseline, indicating that ingested volume may not have 
been absorbed into the extravascular space and that splanchnic pooling was not 
occurring. 
 Fluid loading had no effect on left-ventricular heart performance, 
arterial baroreflex sensitivity, or cardiopulmonary baroreflex. Contrary to 
expectations, these were not compromised by exposure to 28h bed-rest, and 
fluid loading provided no adverse effects. 
This study was not designed to investigate fluid balance or the timing of 
water absorption into the vasculature, but analysis of water intake and urinary 
output suggests is was not excreted. Due to subjects‟ nausea and vomiting, it 
was suggested that some of the ingested water volume remained in the stomach. 
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 One subject experienced presyncopal symptoms during LBNP testing 
following 28h FL HDBR, which resulted in premature termination of 
orthostatic testing. This individual‟s response was likely due to the effects of 
the fluid load itself rather than bed-rest induced cardiovascular deconditioning 
as the subject had vomited following the fluid loading protocol, and had 
previously completed numerous LBNP sessions successfully, even after 28h 
NFL HDBR. Four subjects experienced nausea and two subjects vomited during 
the fluid loading protocol, which is more evidence that this countermeasure 
may be unsuitable. 
Contrary to the hypotheses, fluid loading was not effective at restoring 
lost blood volume resulting from 28h HDBR, nor did it restore any of the 
cardiovascular responses that experienced cardiovascular deconditioning 
following 28h HDBR. 
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5.3 CONTROL TESTS 
Summaries of the raw data used in the analysis of control tests examining the 
effects of circadian rhythm, the fluid loading protocol, and HDBR are 
Appendices A3, A4, and A5 respectively. Summaries of statistical testing 
results for circadian rhythm, fluid loading protocol, and HDBR are provided in 
Appendices B3, B4, and B5. 
5.3.1 EFFECT OF CIRCADIAN RHYTHM 
Cardiovascular variables that were significantly altered by 28h NFL HDBR 
(blood volume, heart rate, CVP, and portal vein diameter) were examined to 
isolate the effects of circadian rhythm. First, pre and post 4h NFL data were 
compared to investigate if there were any circadian effects in the seated 
position. There were no significant differences between pre and post 4h S NFL 
responses regarding total blood volume, plasma volume, hematocrit, heart rate, 
central venous pressure, or portal vein diameter, indicating that there were no 
effects of circadian rhythm in the seated position on these variables.  
To isolate the effects of HDBR from circadian rhythm, the 4h S NFL 
Post and 4h HDBR Post responses were also analyzed. This analysis found that 
there were significant differences in heart rate (p<0.05), central venous pressure 
(p=0.02), and portal vein diameter (p=0.02) due to HDBR, isolating the effects 
of HDBR from circadian rhythm on these variables. Heart rate (p=0.01) and 
portal vein diameter (p=0.04) also experienced significant interaction effects 
between HDBR and LBNP. Blood volume variables were not affected, as after 
4 hours of HDBR, blood volume has returned to its baseline value after a transit 
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increase due to an influx of fluid from the extracellular space in the legs. After 
4 hours of HDBR blood volume begins to reduce below baseline. Figures 5.3-1, 
5.3-2, and 5.3-3 illustrate the heart rate, central venous pressure, and portal vein 
diameter responses during LBNP testing following 4h S NFL and 4h HDBR. 
The pre tests for 4h S NFL and 4h HDBR were also compared, revealing no 
significant differences in baseline conditions.  
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Figure 5.3-1: Heart Rate Response during LBNP Testing following 4h S 
NFL and 4h HDBR (n=8); Post 4hSNFL/4hHDBR HDBR p<0.05, Post 
4hSNFL/4hHDBR LBNP p<0.05, Post 4hSNFL/4hHDBR HDBR-LBNP 
interaction p<0.05 
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Figure 5.3-2: Central Venous Pressure Response during LBNP Testing 
following 4h S NFL and 4h HDBR (n=7); Post 4hSNFL/4hHDBR HDBR 
p<0.05, Post 4hSNFL/4hHDBR LBNP p<0.05 
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Figure 5.3-3: Portal Vein Diameter Response during LBNP Testing 
following 4h S NFL and 4h HDBR (n=9); Post 4hSNFL/4hHDBR HDBR 
p<0.05, Post 4hSNFL/4hHDBR LBNP p<0.05, Post 4hSNFL/4hHDBR 
HDBR-LBNP interaction p<0.05 
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5.3.2 EFFECT OF FLUID LOADING 
To isolate the effects of fluid loading, a single 2-way ANOVA was performed 
comparing 4h S NFL Post and 4h S FL Post test responses (4h NFL Post/4h FL 
Post, LBNP) on the cardiovascular variables that were affected by 28h NFL 
HDBR, including total blood and plasma volume, hematocrit, heart rate, CVP, 
and portal vein diameter. This test concluded that fluid loading protocol did not 
elevate blood volume variables, or have a significant effect on heart rate, CVP, 
or portal vein diameter in the absence of HDBR. Responses from the 4h S NFL 
Post and 4h FL Post tests did not show any statistical differences. Data and 
statistics are summarized in Appendix A4 and B4. The pre tests for 4h S NFL 
and 4h S FL were also compared, revealing no significant differences in 
baseline conditions.  
5.3.3 EFFECT OF HDBR 
To isolate the effects of HDBR, a single 2-way ANOVA was  performed 
comparing 4h S FL Post and 28h FL HDBR Post test responses (4h S FL 
Post/28h FL HDBR Post, LBNP). This analysis indicated that the changes in 
total blood volume, plasma volume, hematocrit, heart rate, and central venous 
pressure seen after 28h FL HDBR were the result of exposure to HDBR. Portal 
vein diameter was not significantly different between 4h S FL and 28h FL 
HDBR, indicating that the changes seen following 28h HDBR were not due to 
bed-rest. Figures 5.3-4 and 5.3-5 show the responses of heart rate and central 
venous pressure following 4h S FL and 28h FL HDBR. Data and statistics are 
summarized in Appendix A5 and B5. The pre tests for 4h S FL and 28h FL 
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HDBR were also compared, revealing no significant differences in baseline 
conditions. 
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Figure 5.3-4: Heart Rate Response during LBNP Testing following 4-hour 
S FL and 28h FL HDBR (n=8); Post 4hSFL/28hFL LBNP p<0.05, Post 
4hSFL/28hFL HDBR-LBNP interaction p<0.05 
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Figure 5.3-5: Central Venous Pressure Response during LBNP Testing 




This study found that, as hypothesized, the cardiovascular system had begun the 
deconditioning process following exposure to 28h of bed-rest. Although 
deconditioning was not as extensive as examples documented after longer 
durations of bed-rest, evidence of cardiovascular deconditioning after 28h 
HDBR included significant hypovolemia, elevated heart rate response, and 
reductions in CVP. Mean arterial pressure was successfully maintained by all 
subjects during post bed-rest orthostatic testing. Systemic vascular resistance, 
left-ventricular function as well as arterial and cardiopulmonary baroreflex 
function were probably not due to hypovolemia as seen with this short-duration 
HDBR, but might have occurred with the deconditioning associated with longer 
bed rest studies. There was also no evidence of splanchnic or venous pooling 
after bed-28h bed-rest.  
 Contrary to the hypothesized outcome, this study also found that 
NASA‟s fluid loading protocol, as employed by Waters et al. (2004), was not 
fully effective at restoring the lost plasma volume resulting from 28h HDBR 
and the subsequent deconditioning. Fluid loading also did not fully prevent the 
elevated heart rate response and reductions in CVP that were seen after 28h 
NFL HDBR. In addition, the fluid loading protocol resulted in increased 
malaise and nausea. Two subjects vomited as a result of the nausea, and one of 
these subjects was unable to complete post bed-rest orthostatic challenge. None 
of these symptoms occurred after 28h NFL HDBR.  It is interesting to note that 
during the 2.5 hour fluid loading period, total blood and plasma volume did 
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progressively increase. It is possible that fluid volume restoration may have 
been successful if the fluid loading protocol had been started earlier. 
 Analysis of the control models indicated that there was no effect of 
circadian rhythm on the cardiovascular responses to HDBR, nor was there an 
effect of fluid loading in the absence of HDBR on the cardiovascular variables 
that were altered following 28h HDBR (total blood volume, plasma volume, 
hematocrit, heart rate, central venous pressure, and portal vein diameter). It was 
also found that the responses seen in these variables following 28h FL HDBR 
were due to bed-rest itself, and not fluid loading. 
HYPOVOLEMIA 
As hypothesized, the circulating blood volume was significantly diminished 
following exposure to 28h HDBR. This study showed that significant 
hypovolemia resulted after 28h HDBR, where plasma volume was reduced by 
8%. The time course of plasma volume changes throughout the bed-rest period 
showed an initial slight increase in plasma volume, peaking after 2 to 3 hours of 
HDBR exposure. The increase was likely due to an influx of extracellular fluid 
into the vasculature of the lower extremities upon assuming the head-down 
position. This study showed a small peak increase of 0.9% after 3 hours of bed-
rest (Hour 0= 3293.6ml, Hour 3= 3321.7ml).  After peaking, plasma volume 
reduced progressively as the cephlad fluid shift caused removal of perceived 
„excess‟ fluid volume by the kidneys. After 4 hours, plasma volume had 
returned to its baseline value (Hour 0 = 3293.6 ml, Hour 4=3292.5 ml). This 
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evidence is supported by the 4-hour bed-rest study by Fischer et al, where total 
blood and plasma volume were unchanged between pre and post measurements 
(Fischer et al. 2007). Blood volume progressively reduced after returning to 
baseline until reaching a steady-state hypovolemic state. After 8 hours, plasma 
volume was reduced by 8.5%. After 28 hours of bed-rest, plasma volume was 
reduced by 7.8% compared to baseline. These small variations in plasma 
volume did not statistically differ from each other and were likely due to 
measurement error or natural variation. These data illustrate that the onset of 
hypovolemia occurs quickly following bed-rest exposure and that the reductions 
in volume level off within the early hours of bed-rest.  
Other studies have found similar reductions in plasma volume after 
longer durations of bed-rest. Waters found an 8% reduction in plasma volume 
and a 5% reduction in total blood volume after 12 days of HDBR (Waters 
2004). Similarly, Vernikos and Convertino found that after 7 days of bed-rest, 
plasma volume was reduced by 12% (Vernikos and Convertino 1994). After 2 
weeks, Iwasaki and colleagues saw a reduction of 12% in plasma volume 
(Iwasaki et al. 2000). Although Bestle and colleagues did not measure plasma 
volume directly during their 9-day bed-rest study, they noted that weight 
significantly decreased by 1.4% (Bestle et al 2001). This is comparable to the 
reduction in weight seen of 1.2% in this study. Together, this evidence 
describes an acute reduction in plasma volume in the hours immediately 
following bed-rest exposure, and the leveling off at a hypovolemic plateau 
within the first days of exposure. 
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ORTHOSTATIC HYPOTENSION 
It was hypothesized that instances of presyncope would arise following 28h 
HDBR. The current study was not designed to test orthostatic tolerance, but it 
was expected that some individuals might have difficulty maintaining arterial 
blood pressure during relatively mild orthostatic stress based on observations 
from previous 4h bed-rest studies (Butler et al. 1991, Fischer et al. 2007). There 
were no observations of presyncopal responses or orthostatic hypotension 
during the relatively mild levels of LBNP employed after the 28h NFL HDBR. 
Subjects were able to maintain arterial blood pressure during a maximum 
orthostatic stress of -40 mmHg, and there were no reports of dizziness or 
nausea. Butler and colleagues (1991) observed that 5 of the 8 subjects could not 
complete a 10 minute tilt test after 4h HDBR, and Fischer and colleagues 
(2007) observed that 3 of 11 subjects experienced presyncope during LBNP 
testing following 4h HDBR. In general, susceptibility to orthostatic hypotension 
appears to increase with time likely because cardiovascular deconditioning 
increases with time. Bed-rest studies of longer duration had higher incidences 
of orthostatic hypotension. In Vernikos and Convertino‟s 7 day HDBR study, 4 
of 5 subjects showed presyncopal symptoms. However, Fischer and colleagues 
saw 3 of 11 subjects experience presyncope following only 4 hours of bed-rest. 
Susceptibility to orthostatic hypotension is not only dependent on the duration 
of bed-rest exposure but on the integrated effects of the individual elements that 
comprise the cardiovascular system.  
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CARDIOVASCULAR DECONDITIONING  
It was hypothesized that cardiovascular deconditioning would result after 28h 
HDBR, manifested during orthostatic testing as elevated tachycardia, reduced 
stroke volume, reduced cardiac output, and reduced central venous pressure, as 
well as an increased vasoconstriction response and reduction of the 
vasoconstrictor reserve. As hypothesized, evidence of cardiovascular 
deconditioning was apparent following 28h bed-rest in the form of an elevated 
heart rate response during orthostatic stress. However, this was not 
accompanied by a significant change in stroke volume despite a significant 
reduction in CVP (although there was a trend towards a reduction of stroke 
volume). Cardiac output and TPR also remained unchanged after 28h NFL 
HDBR. This evidence indicates that there are different stages of cardiovascular 
deconditioning, with heart rate and central venous pressure being the first 
cardiovascular variables to be affected. Reductions in stroke volume, cardiac 
output and TPR follow sequentially as deconditioning becomes more severe. 
Vernikos and Convertino (1994) observed deconditioning of all these responses 
after 7 days of HDBR.  
This study‟s hypotheses included a statement that vasoconstrictor 
reserve would be diminished following 28h HDBR. It is not known if 
vasoconstrictor reserve was affected by 28h HDBR. There was no change in 
baseline TPR, or in the TPR response to orthostatic stress. However, 
progressive LBNP testing from 0 mmHg to -40 mmHg was insufficient to 
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produce a plateau in TPR before and after 28h HDBR, therefore no information 
on vasoconstrictor reserve was obtained. 
In the current study, the small reductions in stroke volume during LBNP 
were not significant, although the increase in heart rate suggests a 
cardiovascular compensation. These data can be put in the perspective of an 8% 
reduction in plasma volume that was similar to several longer duration studies 
that reported significant changes in stroke volume, cardiac output, and total 
peripheral resistance (Vernikos and Convertino 1994, Waters 2005, Zhang 
2001). From the current study, it appears that HDBR-induced hypovolemia is 
not the only mechanism for cardiovascular deconditioning, contrary to the 
hypotheses of many studies (Convertino et al 1990, Iwasaki et al. 2000, Sawka 
et al. 1999, Steiner et al. 2007, Waters et al. 2005). It is possible that the 
changes in heart rate and central venous pressure resulting from short duration 
bed-rest are primarily due to hypovolemia, although there is no conclusive 
evidence in this study to distinguish between the effects of short term bed-rest 
and hypovolemia. It is likely that deconditioning of cardiovascular variables 
such as stroke volume, cardiac output, and systemic vascular resistance is a 
stronger contributor to onset of syncope after bed-rest than hypovolemia. This 
conclusion is supported by data from this study, since no instances of syncope 
arose despite significant hypovolemia after 28h HDBR. It is also supported by 
Fischer et al, who saw 3 of 11 subjects succumb to syncope while there was no 
change in plasma volume (Fischer et al. 2007). 
 
 122 
SPLANCHNIC BLOOD FLOW 
It was hypothesized that differential vasoconstriction would occur following 
28h HDBR, leading to splanchnic pooling and impacting blood pressure 
maintenance; TPR would be elevated at baseline, whereas splanchnic 
vasoconstriction would be diminished. Contrary to the results seen by Fischer 
after four hours of bed-rest (Fischer et al. 2007), this study showed that 
splanchnic vasoconstriction was increased following 28h NFL HDBR.  
Splanchnic vasoconstriction may play an important role in maintaining 
blood pressure. As the cardiovascular system becomes stressed, sympathetic 
nervous system activation causes systemic vasoconstriction that can facilitate 
return of blood to the heart and act with the increased heart rate due primarily to 
parasympathetic withdrawal to maintain cardiac output. Sympathetic activation 
may also cause changes in splanchnic vasoconstriction. Splanchnic 
vasoconstriction increases with orthostatic stress, reducing the blood volume in 
the splanchnic areas and directing blood to the heart to protect blood pressure. It 
would be expected that the splanchnic vasoconstriction response would be 
increased after bed-rest in order to maintain blood pressure and support 
orthostasis and also due to hypovolemia. However, research has indicated that 
there can be differential responses in the splanchnic blood flow with orthostasis. 
Stewart and colleagues found that a subset of patients suffering from postural 
tachycardia syndrome (POTS) exhibited increased splanchnic blood flow and 
splanchnic pooling during orthostatic stress in spite of excessive peripheral 
vasoconstriction (Stewart et al. 2005). Splanchnic hyperemia has also been seen 
 123 
following bed-rest studies. Fischer and colleagues found evidence of increased 
splanchnic pooling in the form of increased portal vein diameter and portal vein 
blood flow following a bed-rest period as short as 4-hours (Fischer et al. 2007). 
Arbeille and colleagues found evidence of both unchanged and reduced 
splanchnic vasoconstriction responses following 60 and 85 days of bed-rest, in 
spite of significant hypovolemia (Arbeille et al 2008, Arbeille et al 1005). 
This study yielded no evidence of splanchnic pooling after 28 hours of 
HDBR. Portal vein diameter was significantly reduced after bed-rest, indicating 
reduced splanchnic blood flow and providing evidence that the splanchnic 
vasculature was directing blood to the systemic vasculature where it is needed. 
Splanchnic impedance was unchanged following 28h bed-rest, providing a 
further indication that splanchnic pooling was not occurring. It must also be 
restated that no subjects experienced presyncopal symptoms in their natural 
response to 28h HDBR. This study‟s 4 hour HDBR control tests showed that 
after 4 hours of exposure the subjects had no change in splanchnic blood flow 
as portal vein diameter and splanchnic impedance were unchanged. These 
findings contrast those of Fischer‟s. Despite a shorter duration of exposure to 
HDBR, Fischer and colleagues noted 3 instances of presyncope, whereas in this 
study, subjects were exposed to 24 additional hours of bed-rest, but no 
presyncopal symptoms arose (Fischer et al 2007). It is interesting to note that 
the two studies were performed under similar laboratory conditions (testing 
protocol, LBNP stress, food intake and timing) and subject attributes (male, age 
range, fitness level, LBNP testing experience). This evidence supports previous 
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conclusions that increased splanchnic blood flow is detrimental to post bed-rest 
orthostatic testing success. It is expected that within the population, individuals 
exhibit a wide range of splanchnic vasoconstriction responses to orthostasis. 
While the subjects in this study demonstrated the ability to reduce their 
splanchnic blood flow and volume during orthostatic stress, POTS patients 
represent the other end of the spectrum. Arbeille and colleagues found that the 
splanchnic vasoconstriction response was a differentiating feature between 
finishers and nonfinishers of orthostatic testing following 60 days of HDBR. A 
reduced vasoconstriction response after bed-rest was associated with orthostatic 
intolerance (Arbeille et al. 2008). When considered with Fischer‟s data, this 
study provides further evidence of the different physiologies exhibited in the 
general population. 
Abnormal splanchnic vasoconstriction may be another mechanism of 
the cardiovascular system that suffers deterioration with progressive exposure 
to bed-rest. It is possible that the proportional increase in splanchnic blood flow 
exhibited by subjects after 60 and 85 days of bed-rest is caused by prolonged 
exposure to reduced cardiovascular stress rather than their innate physiology 
(Arbeille et al 2005, Arbeille et al 2008). Systemic vasoconstriction is thought 
to respond to reductions in aortic pulse pressure, whereas splanchnic vascular 
resistance responds to reductions in right atrial pressure. This indicates that the 
splanchnic vascular bed may be more sensitive to signaling from the arterial 
baroreflex than from the cardiopulmonary baroreflex (Rowell et al. 1970). This 
explains the differential responses of the two vascular beds and that splanchnic 
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deconditioning likely begins after changes in systemic vasoconstriction since 
aortic pulse pressure reductions occur later in the deconditioning process than 
reductions in venous return. It must be noted that in this study pulse pressure 
and arterial baroreflex were not affected after 28 hours of HDBR, and 
splanchnic vasoconstriction was significantly increased. It is also possible that 
splanchnic resistance was increased as a result of bed-rest induced 
hypovolemia, although this cannot be definitively stated. 
ARTERIAL BAROREFLEX 
It was hypothesized that arterial baroreflex sensitivity would be 
attenuated after 28 hours of HDBR, which would be reflected in reduced gain 
and increased phase „lag‟ results of transfer function analysis performed on SBP 
and R-R Interval signals (described in Section 4.9.9). However, transfer 
function analysis revealed no differences in gain or phase responses between 
pre and post 28h NFL HDBR. This illustrates that arterial baroreflex is not 
altered during bed-rest sessions as short as 28 hours, meaning that the change in 
arterial pressure needed to elicit a given change in heart rate is not changed 
within short durations of bed-rest exposure.   
When integrating these results into the existing body of data, it can be 
concluded that attenuation of arterial baroreflex is a progressive process that 
increases with longer bed-rest exposure. Evidence of arterial baroreflex 
attenuation was not apparent after 28h bed-rest, but there is evidence of such 
deconditioning after longer bed-rest durations. Evidence accumulated from a 
variety of methods, include neck suction and transfer function analysis, 
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illustrate that prolonged bed-rest has a negative impact baroreflex function. 
Exposure to 7 days, 14 days, 28 days, 30 days, 60 and 120 days of bed-rest all 
exhibited significant arterial baroreflex attenuation (Vernikos and Convertino 
1994, Iwasaki et al 2000, Hughson et al. 1994, Convertino et al 1990, 
Linnarsson  et al. 2006). Since many diverse methods have been used to 
measure these parameters, it is not possible to compare these data sets regarding 
the relationship between arterial deconditioning and bed-rest duration. 
However, a study performed by Convertino and colleagues found that arterial 
baroreflex attenuated progressively during 30 days of bed-rest. Reductions 
initially became apparent after day 15 and progressively worsened until day 25 
(Convertino et al 1990). The results of this study fit in with these data, 
supporting the hypothesis that arterial baroreflex attenuation is not a result of 
acute bed-rest, rather the degree of attenuation increases with the duration of 
exposure. 
Hypovolemia has been hypothesized to be the principal cause of arterial 
baroreflex attenuation that arises following bed-rest exposure. There are 
extensive data relating altered arterial baroreflex function to acute hypovolemic 
conditions, resulting from hemorrhage or induced hypovolemia (Triedman 
1993, Saitoh et al. 2008, Blake 2000, Sopher et al. 1990, Wang et al. 1990). 
Since hypovolemia is a known consequence of bed-rest, Iwasaki and colleagues 
(2000) hypothesized that the attenuation in arterial baroreflex function seen 
after bed-rest is due to hypovolemia rather than cardiovascular deconditioning. 
Their study found that arterial baroreflex function reduced similarly after 2 
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weeks of bed-rest and acute hypovolemia by furosemide. Bed-rest and acute 
hypovolemia both resulted in reductions in plasma volume of 11-12% providing 
an indication that hypovolemia may be responsible for baroreflex attenuation 
(Iwasaki et al 2000). However, the results of this study suggest that 
hypovolemia is not the principal mechanism in bed-rest related baroreflex 
attenuation. Although plasma volume was reduced by 8% with 28 hours of bed-
rest, there were no significant alterations in the gain and phase results of the 
transfer function analysis of R-R interval and SBP signals in the MF and HF 
regions attributed to arterial baroreflex regulation. Therefore, significant 
reductions of blood volume do not lead to arterial baroreflex attenuation during 
periods of 28 hour bed-rest. Convertino and colleagues (1990) found that during 
a 30 day bed-rest study, the changes in plasma volume did not occur in parallel 
with the attenuation of arterial baroreflex. A 15% reduction in plasma volume 
stabilized within the first days of bed-rest. However, the arterial baroreflex 
response only began to decline after 12 days of bed-rest. Taken together, these 
data indicate that that although plasma volume may play a role in baroreflex 
attenuation, it is not the sole or primary contributor to the attenuation seen after 
bed-rest. Instead hypovolemia may be a secondary factor supporting the 
cardiovascular deconditioning that leads to reduction in arterial baroreflex 
function. Lastly, it is suggested that hypovolemia resulting from bed-rest and 
acute hypovolemia resulting from hemorrhage or medication likely represent 
very different physiological conditions. 
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The causes of progressive arterial baroreflex attenuation during bed-rest 
may be due to peripheral resetting of the baroreflex response. Peripheral 
resetting is defined by Chapleau and colleagues (1989) as a „shifting of the 
pressure-baroreceptor activity curve in the direction of the prevailing arterial 
blood pressure‟. This describes the alteration of baroreceptor function due to 
adaptation of the mechanical properties of the conduit arteries to prolonged 
exposure to a hypertensive or hypotensive state. Arterial vascular compliance is 
a principal determinant in the magnitude of arterial deformation experienced 
during transmission of a pressure pulse, and therefore has profound effect on 
the degree of baroreflex stimulation (Lanfranchi and Somers 2002). Arterial 
vascular compliance can be defined as the change in stroke volume over the 
change in pulse pressure (Chemla et al. 1998). It has been shown that 
hypertensive subjects generally have a lower arterial compliance than 
normotensive individuals, and this reduction in compliance occurs concurrently 
with reductions arterial baroreflex sensitivity (Dart et al. 1993, O‟Rourke et al. 
1990, Pagani et al. 1988, Somers et al. 1991). Arterial compliance has been 
increased in both hypertensive and normotensive subjects through moderate 
exercise training, and arterial baroreflex sensitivity restored, showing that not 
only are arterial baroreflex and arterial compliance related, but arterial 
compliance adapts to the level of cardiovascular stress imposed on the body and 
this in turn affects baroreflex function.  
Arterial compliance may play a similar role in bed-rest related arterial 
baroreflex attenuation since reductions in arterial vascular compliance increase 
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longer duration exposure. Once bed-rest induced cardiovascular deconditioning 
has led to reductions in stroke volume, arterial vascular compliance is 
consequently reduced. This may have the same implications reductions in 
arterial compliance have on hypertensive individuals and be the cause of arterial 
baroreflex attenuation by reducing the ability for the baroreceptors to detect 
reductions in blood pressure. This may explain why arterial baroreflex 
reductions occur long after hypovolemia has been established. Rather than 
resulting from hypovolemia, arterial baroreflex occurs when stroke volume 
becomes diminished. Following 28 hours of bed-rest there were no reductions 
in stroke volume, nor reductions in arterial vascular compliance, and 
consequently there was no evidence of baroreflex attenuation. The bed-rest 
studies previously mentioned provided evidence of deteriorating arterial 
baroreflex as well as reductions in stroke volume after 7 days, 28 days, 30 days, 
60 and 120 days of bed-rest (Iwasaki et al 2000, Hughson et al. 1994, 
Convertino et al 1990, Linnarsson et al. 2006).  
LEFT VENTRICULAR PERFORMANCE 
The results of this study indicate that, contrary to the hypothesized outcome, 
there were no changes in left-ventricular heart function after 28 hours of HDBR 
despite hypovolemia and reduced central venous pressure. There were no 
changes in fractional shortening and ejection fraction when comparing pre and 
post data.  
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Previous studies have shown that the heart adapts to changes in loading 
conditions when exposed to long periods of bed-rest. The acute adaptations to 
HDBR include hypovolemia, reductions in central venous pressure, and a 
prominent drop in left ventricular filling. Researchers have also seen evidence 
of diminished cardiac function after bed-rest. Takenaka and colleagues saw 
reductions in left ventricular dimensions following 20 days of bed-rest, which 
led to reductions in stroke volume and cardiac output, and orthostatic 
hypotension (Takenaka 1997). Levine and colleagues showed that there was 
evidence of LV mass reduction after only 12 as well as after 18 days of bed-rest 
(Levine et al. 1997, Levine et al.1999).  Following 60 day of HDBR, Dorfman 
and colleagues noted reductions in left ventricular volumes and masses 
(Dorfman et al. 2007).  
The data from this study indicate that despite reduced cardiac filling, left 
ventricular function is not affected within bed-rest exposure as short as 28 
hours. Rather, it is thought that that cardiac remodeling occurs after significant 
exposure to bed-rest (at least 12 days) and the corresponding chronic reduction 
in cardiac filling (Dorfman et al. 2007). Perhonen and colleagues saw 
significant and progressive reduction in cardiac function in sedentary subjects 
who underwent 6 and 12 days of bed-rest (Perhonen et al 2001). Reductions in 
left ventricular end-diastolic volume stabilized after 2 weeks but there was a 5% 
reduction in left ventricular mass following 2 weeks of bed-rest, 8% reduction 
after 6 weeks, and 16% reduction after 12 weeks (Perhonen et al. 2001). 
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 The data from this study also support the hypothesis that cardiac atrophy 
is a progressive process since no changes in left ventricular function were seen 
during only 28 hours of HDBR despite a significant reduction in plasma 
volume. The heart is able to function normally under reduced myocardial load 
resulting from hypovolemia.  Instead, chronic hypovolemic results in a 
sustained reduction in volume loading of the heart, which leads to slow but 
progressive impairment of cardiac function. 
 This hypothesis is also supported by data from Dorfman and colleagues 
who studied women who exercised and women who underwent a natural 
response during 60 days of bed-rest. Interestingly, the women who exercised 
did not experience reductions in left ventricular volumes and the length of the 
major axis was preserved, which contrasted the results of the women who did 
not exercise (Dorfman et al. 2007). These data indicate that diminished cardiac 
function can be prevented by adequate cardiovascular stress during bed-rest. 
Therefore, chronic exposure to hypovolemia and lack of cardiovascular stress is 
likely the cause of heart dysfunction following prolonged bed-rest. 
CARDIOPULMONARY BAROREFLEX 
It was hypothesized that following 28h HDBR, the cardiopulmonary baroreflex 
would be elevated, illustrated by an increased forearm vascular resistance 
response throughout orthostatic testing. However, there was no evidence of an 
altered cardiopulmonary baroreflex response after 28h NFL HDBR. Forearm 
vascular resistance data was not used for the analysis due to the presence of 
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measurement error. However there were no changes in supine brachial diameter 
or brachial blood flow, nor was the brachial blood flow velocity response 
changed after bed-rest. This indicated that the magnitude and set-point of the 
cardiopulmonary baroreflex response was unchanged. 
 These data fit well with the systemic vasoconstriction data discussed 
earlier, indicating the vasoconstriction response was unchanged by bed-rest, and 
is a further indication that systemic vasoconstriction is not primarily a result of 
bed-rest induced hypovolemia. This is contrary to the results of Vernikos and 
Convertino, who determined that the cardiopulmonary baroreflex was increased 
following 7 days of bed-rest, attributing the elevation to hypovolemia (Vernikos 
and Convertino 1994). 
EFFECT OF FLUID LOADING PROTOCOL 
This study found that, contrary to the hypothesized outcome, fluid loading was 
ineffective at both restoring blood volume (its primary purpose) and preventing 
cardiovascular deconditioning (its secondary purpose). Total blood and plasma 
volume were not significantly different following bed-rest with fluid load 
compared to their natural response to bed-rest. After the fluid loading protocol, 
plasma volume remained reduced by 9.8 %.  
Fluid loading did not alter the physiological responses to bed-rest 
compared to the natural responses to 28h bed-rest. Completion of fluid loading 
following 28 hours HDBR still resulted in the same evidence of cardiovascular 
deconditioning as seen following 28h bed-rest: reductions in mean arterial 
 133 
pressure during post bed-rest orthostatic testing, orthostatic tachycardia, and 
reduced central venous pressure. Cardiovascular variables that were unchanged 
by bed-rest remained unchanged following bed-rest with fluid load. These 
included stroke volume, cardiac output, systemic vasoconstriction, splanchnic 
hemodynamics, and left ventricular performance. Taken together, this illustrates 
that the cardiovascular deconditioning resulting from 28h bed-rest was not 
prevented by the fluid loading protocol. In addition, the onset of nausea in the 
bed-rest position may be evidence that water remained in the stomach and was 
not absorbed in to the vasculature. 
Fluid volume replacement is a practice commonly used in hospitals to 
reduce the degree of vasoconstriction, heart rate and renin-angiotensin-
aldosterone system responses required to maintain blood pressure. It was 
adopted by the space program to support blood pressure regulation during re-
entry, a period where astronauts must be capable of responding quickly. Two 
studies have previously investigated the efficacy of NASA‟s fluid loading 
protocol, however this is the first study that compares the subjects‟ natural 
response following bed-rest to their response following fluid loading, while 
using NASA‟s prescription of salt and water. 
These findings counter the results of Water‟s study, which found no 
evidence of cardiovascular deconditioning following 12 days of bed-rest with 
fluid loading. However, Waters‟ results should be viewed with caution since the 
subject‟s natural cardiovascular response to orthostatic stress following bed-
rest, without the effects of fluid loading, was not measured. Cardiovascular 
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responses (including blood pressure, stoke volume, cardiac output, CVP, and 
ejection fraction) were only measured on day 13 following completion of the 
fluid loading protocol. Therefore, the subjects studied by Waters and colleagues 
may not have been affected by bed-rest to the degree that cardiovascular 
deconditioning would be apparent in the variables measured, and fluid loading 
may not have „restored‟ deconditioned variables. 
The data presented in this paper compliment the results of Vernikos and 
Convertino‟s study in which significant deconditioning was found after 7 days 
of HDBR. Vernikos and Convertino‟s data showed a reduction of mean arterial 
pressure during orthostatic stress following bed-rest. Stroke volume and central 
venous pressure were reduced, heart rate and vasoconstriction responses were 
elevated, as well as attenuation of the carotid baroreflex and up-regulation of 
the cardiopulmonary baroreflex. Blood volume was not restored by the fluid 
load, and significant evidence of cardiovascular deconditioning was present.  
One of the most interesting results was that fluid loading increased the 
incidence of presyncopal conditions in both the 28h FL test as well as the 4-
hour fluid loading control test. Some subjects experienced feelings of nausea 
and could not complete the fluid loading protocol. Within this group of 
subjects, a smaller portion experienced vomiting and succumbed to syncope 
testing. This is the strongest evidence against the use of salt and water as a fluid 
volume replacement strategy. Not only does the protocol fail to replace volume 
or support blood pressure regulation, it can also illicit symptoms of malaise and 
cause presyncopal symptoms in a subject who completed orthostatic testing 
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after 28 hours of bed-rest successfully. Once again, it must be reiterated that 
subjects who vomited or did not complete the fluid loading protocol were not 
included in the statistical analysis investigating fluid loading, however their 
response to the fluid loading protocol must be highlighted. 
In contrast to Water‟s study (Waters et al. 2004), where blood volume 
was restored by fluid loading, this study did not result in full restoration of 
blood volume after the bed-rest period. The protocol used in this study, as well 
as that of Waters,  followed NASA‟s fluid loading prescription of oral 
consumption of 1 g salt tablet per 125 ml water with a total volume of 15ml/kg 
within a 2 hour period prior to orthostatic challenge. However, where Waters 
fully restored the 8% plasma volume loss after 12 days, our study failed to 
restore the 12% plasma volume loss that resulted after 28 hours. The reasons for 
this may include onset of nausea and vomiting experienced in some subjects 
(such reactions are not mentioned by Waters, although it is important to 
reiterate here that subjects who did not complete the fluid loading protocol were 
not included in the statistical analysis of fluid loading efficacy), as well as the 
time course of salt and water uptake into the vasculature. Urine output was not 
significantly different between the 28h NFL and 28h FL tests, although there 
appeared to be more urine excreted during FL testing compared to NFL testing. 
No information on extracellular fluid volume is known, so filtration into the 
extravascular space is unknown. However, due to the prevalence of nausea in 
the head-down position during the fluid loading period, it is suggested that a 
portion ingested salt and water remained in the stomach and was not yet fully 
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absorbed into the vasculature. In this study, the fluid loading prescription was 
separated into increments of one salt-filled capsule of approximately 1 gram 
and the corresponding water intake cumulating into approximately 10 tablets 
taken in twelve minute increments across the two hour fluid loading period 
(with small deviations depending on individual subject‟s weight). Neither 
Vernikos and Convertino nor Waters and describe how their fluid loading 
prescription was delivered throughout the 2 hour period. The timeline for 
consumption may also play a significant role in the physiological effects of 
fluid loading in addition to the prescription of salt and water. 
ROLE OF HYPOVOLEMIA IN CARDIOVASCULAR DECONDITIONING 
The role of hypovolemia in cardiovascular deconditioning and orthostatic 
hypotension has been a topic of debate. Researchers (Iwasaki et al. 2000) have 
hypothesized that hypovolemia resulting from bed-rest is the primary cause of 
deconditioning, causing reductions in stroke volume, increased vasoconstriction 
response, affecting left-ventricular function by altered pre-load and ventricular 
filling. However, data from this study and others (Vernikos and Convertino 
1994) support the argument that cardiovascular deconditioning occurs 
independently from bed-rest induced hypovolemia. For example, cardiovascular 
variables such as stroke volume, TPR, and ejection fraction were unchanged 
following 28 hours HDBR, despite a 12% plasma volume loss. Aortic 
baroreflex was also unaffected by 28h HDBR.  Waters and colleagues (2005) 
data also provide supporting evidence. In their study, the 8% reduction in fluid 
volume after 12 days was fully restored; however heart rate, systemic 
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vasoconstriction, stroke volume, cardiac output and central venous pressure 
responses were significantly impacted. Taken together, it is suggested that 
hypovolemia is an acute reaction to HDBR, but cardiovascular deconditioning 
is a progressive process that worsens with increasing bed-rest exposure and is 
not a direct result of hypovolemia. If in fact cardiovascular deconditioning is 
independent of bed-rest induced hypovolemia, the rationale of seeking a 
countermeasure to restore fluid volume in order to prevent orthostatic 
hypotension should be re-considered. 
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7 LIMITATIONS 
This study was limited by several factors. Most importantly, it should be 
mentioned that the results from this study are directly applicable to men 
undergoing bed-rest in a terrestrial environment. Research has shown that the 
responses of astronauts returning from spaceflight may differ from those of bed-
rest due to additional neurovestibular problems and other factors. Fluid 
dynamics differ greatly between terrestrial bed-rest and space, since gravity is 
still acting on the body during bed-rest. Additionally, women may exhibit 
different responses due to their menstrual cycle. Therefore additional research is 
needed to apply these results to women and astronauts. 
The subject pool for this study was small. Only nine subjects were tested 
due to the time demands of performing 5 testing protocols. It was a demanding 
time commitment as two of the protocols required over 30 consecutive hours of 
laboratory time, and the remaining three required 8 hours. Test scheduling was 
limited by subjects´ personal schedules, laboratory and equipment scheduling, 
as well as maintaining adequate recovery time between testing session to 
prevent confounding effects. P values are presented wherever possible due to 
the small subject pool as recommended by Hathaway and colleagues (Hathaway 
et al. 1997).  
 It must be made clear that this study was not designed to measure the 
subjects„ orthostatic tolerance. Rather, this study was designed to examine the 
relative changes in cardiovascular responses following each protocol and 
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quantify if cardiovascular deconditioning had occurred. Tolerance is determined 
by standardized protocols such as a tilt tests with LBNP as performed in the 
WISE study (Arbeille et al. 2005). Since this study analyzed each subject‟s 
physiological response during a progressive LBNP test, and did not perform a 
standardized test, conclusions cannot be made defining a subject as 
orthostatically tolerant or intolerant.  
It must also be mentioned that this study focused on testing the efficacy of 
NASA‟s fluid loading protocol of water intake coupled with salt tablets. There 
are other similar methods thought to increase blood volume prior to re-entry, 
such as ingestion of soup broth which is commonly used by the Russian space 
program. While similar in principal, bouillon contains additional electrolytes 
and potentially glucose, which likely result in different digestion dynamics than 
NASA‟s protocol. Additionally, the taste and smell of bouillion would likely 
prevent feelings of nausea exhibited by salt and water ingestion. Therefore, 
these results may not be applicable to the broad methodology of fluid loading to 
restore normovolemia following space flight. Additional work must be done to 
examine other methods. 
Another major limitation concerning the presented data is that the study 
was not designed to focus on only the cardiovascular variables presented in this 
paper. The data collected were part of a large series of bed-rest studies that were 
the data source for 3 Masters theses and one PhD thesis. In addition to the 
cardiovascular variables presented here, data collection included blood analysis, 
urine, diet analysis, and cardiac impedance. Therefore, the protocol planning 
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involved compromises to allow for all the desired datasets being reliably 
collected.  For example, arterial baroreflex data required continuous R-R 
Interval and SBP data sets to be collected, and the quality of analysis was 
dependant on the length of the data set. At the same time, the accuracy of 
Finometer measurements of BP and Q was essential, as it was the basis for the 
collective research. Measurement accuracy required Physiocal, a Finometer 
calibration signal, to be enabled to periodically measure finger blood vessel 
diameter. Changes in vessel diameter occur when adapting to orthostatic 
challenge. However, Physiocal caused the datasets to be non-continuous as 
blood pressure is not measured during the 3 beats it used to measure vessel 
diameter. For these reasons Physiocal remained on during the 28h protocol for 1 
minute and 15 seconds following an increase in orthostatic stress, and also was 
turned on 15 seconds prior to a change in LBNP.  Arterial baroreflex data were 
collected in the remaining 3 minutes and 30 seconds at 0, -20, and -40 mmHg. 
Physiocal remained enabled throughout 4-hour bed-rest orthostatic testing 
protocols due to the wishes of another researcher using data from those 
protocols. Also, use of a metronome at 0.15 Hz to regulate breathing had been 
proposed to maintain a high power at 0.15 Hz and create a defined respiration 
frequency. Since there was concern this would alter other physiological 
responses that were the focus of other members of the research group, 
especially at higher levels of orthostatic stress when most subjects naturally 
increase their breathing frequency, a metronome was not used.  
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 It must be noted that 6 of the 9 subjects had never participated in a bed-
rest study before. Since it was often not possible to subject them to LBNP 
testing prior to their participation in the study, the order the 5 protocols were 
performed in was randomized to reduce the physiological stress of a new 
experience. We were not able to adapt our subjects to a specific circadian 
rhythm before they participated in the study. Each testing session began at 7 
am, which was often not the time the subject would normally wake up at. 
Therefore their circadian rhythm was disrupted during each test. However, 
since each subject participated in each protocol, and their natural sleeping 
rhythm was disrupted similarly during each of the 5 protocols, it is thought that 
these effects will be similar across all the testing protocols. Due to scheduling 
limitations, some subjects participated in testing over a period of 6 months. It is 
a possibility that their body composition changed over that time period, 
however an examination of their masses did not reveal significant changes, nor 
did their levels of physical activity change. 
 Diet would have been ideally controlled in the days leading up to each 
test in order to know specific salt intakes. However this was not possible since 
the study lacked the funding needed to provide food to subjects in the days 
leading up to the test.  
Another variable that was considered during testing was ingested water 
during the bed-rest period.  Subjects‟ fluid intakes were determined from their 
thirst on their first testing day, with subsequent tests allowing them that amount 
with a 25% buffer. Ingested water varied greatly between subjects. Subjects 
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would often experience a different thirst response during subsequent tests and 
ask for the amount to be reduced or increased, though it was maintained as 
consistently as possible. It is debatable whether subjects should have been 
allowed to drink ad libitum, or had their intake regulated for comparable 
conditions. Nevertheless, analysis illustrated that the variation in water intake 
across the subject pool was not related to performance during orthostatic testing 
following bed-rest. 
To support fluid volume measurements, fluid intake and urine output, it 
would have been useful to gauge water output through respiration, perspiration, 
and defecation. However, due to laboratory constraints, it was not possible to 
collect these data. Thus we can only provide a rough indication of fluid 
distribution following fluid loading and cannot be sure how much fluid was 
absorbed into the extracellular (of particular interest) and intracellular fluid 
volumes. 
Nausea was experienced by several subjects during the fluid loading 
protocol. This must be taken into consideration when examining their responses 
to orthostatic stress following bed-rest. Two subjects vomited, which impacted 
their blood volumes. Therefore, their responses were not included in the 
analysis of fluid volume efficacy. Feelings of malaise associated with nausea 
may have contributed to increased heart rate response and reductions in blood 
pressure.  
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There was measurement error present in some measurement techniques. 
Measurements of cardiac output using two different methods were not similar 
(aortic blood flow velocity by the Doppler ultrasound versus Finometer 
estimation). Finometer estimation of cardiac output was used in the analyses 
since it followed trends exhibited by previous bed-rest research and also 
resulted in statistically similar pre test responses. Doppler ultrasound may have 
resulted in erroneous aortic blood flow velocity data due to changes in the 
ascending aorta anatomy during increasing orthostatic stress. Figures D-1, D-2, 
D-3, and D-4 in Appendix D illustrate the stroke volume, cardiac output, total 
peripheral resistance and arterial compliance responses pre and post 28h NFL 
HDBR using Doppler Ultrasound. 
 As described earlier, portal vein blood flow velocity data did not follow 
the typical trend recorded in previous studies with LBNP testing. While this 
may have been physiological, there are also sources of measurement error in the 
ultrasound technique as probe placement during velocity measurement is not 
visualized. When examining an individual‟s response at a specific level, 
averages were taken of up to 9 ultrasound images of portal blood flow. Often 
these samples were similar; however there were cases where a subject exhibited 
a wide range of flows at a specific level of LBNP. The different response can be 
partly attributed to respiration shifting the vessel out of view during 
measurement, affecting the overall average during the window. Figure 7-1 
provides an image without respiration on the left and with respiration on the 
right, with portal blood flow recorded for each. These images are taken from the 
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same subject at the same level of LBNP (-20 mmHg). It was not uncommon, 
especially at high levels of LBNP, for respiration to affect every measurement 
due to an increased breathing frequency. For this reason, regions of the image 
where portal blood flow was affected by respiration were not included in the 
analysis. There were also cases where the portal flow averaged over the entire 
window, without respiration, yielded a very different response compared to 
another sample taken at the same level. Figure 7-2 provides an illustration of 
this. Measurements of portal blood flow were taken with the probe in the same 
position used for portal vein diameter on the same subject at the same level of 
LBNP stress. The blood flow velocity in these two images varied between 
26.23 cm/s and 19.54 cm/s. It was not possible to see the placement of the gate 
in real time while measuring portal blood flow. Therefore, it is possible that the 
gate was not surrounding the entire blood vessel during measurement, leading 
to an erroneous result. Without a real-time updated image of probe placement, it 
is impossible to discern which measurements are erroneous and which provide a 
reliable result. Figure E-1 and E-2 in the Appendix E illustrate the measured 
portal blood flow responses following bed-rest and fluid loading. Therefore, 
portal vein diameter measurements are relied upon to describe the splanchnic 
vasculature dynamics, as described by Arbeille (Arbeille et al. 2003). 
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Figure 7-1: Effect of Respiration on Portal Blood (Subject ID: ZS, LBNP 
Level: -20 mmHg) 
 
 
Figure 7-2: Variation of Portal Blood Flow Velocity with one LNBP Level 
(Subject ID: ZS, LBNP Level: -30 mmHg) 
Cardiopulmonary baroreflex data was initially planned to be analyzed 
by investigating the relationship between forearm vascular resistance and 
LBNP, as described in Section 4.9.10 and by Vernikos and Convertino 
(Vernikos and Convertino 1994).  However the data from this study did not 
follow the trends published previously. As expected, brachial blood flow 
velocity diminished with increasing orthostatic stress. However brachial blood 
flow (which contains brachial blood flow velocity, heart rate, and brachial 
diameter in its calculation) was constant with increasing orthostatic stress. 
Brachial blood flow is expected to diminish, corresponding to an increase in 
Flow = 23.50cm/s Flow = 20.55 cm/s 
Flow = 26.23 cm/s Flow = 19.54 cm/s 
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forearm vascular resistance. This unexpected result may be attributable to use 
of supine brachial artery diameter for subsequent measurements of brachial 
blood flow during orthostatic testing. Unfortunately it was not possible to 
measure brachial artery diameter during orthostatic testing due to use of 
different probes and interference with CVP and brachial blood flow velocity 
measurements. Graphs of forearm vascular resistance responses to increasing 
orthostatic stress pre and post 28h NFL HDBR (Figure F-1) and post NFL and 
FL HDBR (Figure F-2) are available in Appendix F. Since cardiopulmonary 
baroreflex could not be examined by forearm vascular resistance responses, 
brachial diameter and brachial blood flow velocity responses were examined to 
provide an indication on cardiopulmonary baroreflex responses following bed-
rest and fluid loading. 
Measurements of IVC diameter at high levels of LBNP should be taken 
with caution as respiration and alterations in anatomy made it difficult to 
measure diameters in the same location used during low levels of LBNP. It 
should be mentioned that the standard error in IVC measurements at -40 mmHg 
was not greater than measurements at lower levels, indicating the reliability of 
the measurements (and justifying their use inclusion in the analysis). An 
example of an ultrasound image of IVC diameter at 0 mmHg is provided in 
Figure 7-3, and examples of images taken at -40 mmHg are illustrated in Figure 
7-4 and Figure 7-5 respectively.  The images are taken on the same subject 
during 28h NFL HDBR Post testing. Figure 7-4 provides a good quality image 
for IVC diameter measurement at -40 mmHg due to clarity and IVC position, 
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whereas Figure 7-5 was not as desirable image since the IVC was viewed in a 
different position compared to the image taken at 0 mmHg. When available, 
images such as Figure 7-4 were used in analysis of IVC diameter. Otherwise, as 
many measurements of IVC diameter as possible were measured from available 
images to increase accuracy. Analysis showed that the measured IVC diameter 
was clearly reduced with each level of increasing stress despite measurement 
difficulties at higher levels of LBNP. 
 





Figure 7-4: IVC Diameter at -40 mmHg during 28h NFL HDBR Testing 
for Subject 9 (IVC in same position as 0 mmHg image) 
 
Figure 7-5: IVC Diameter at -40 mmHg during 28h NFL HDBR Testing 
for Subject 9 (IVC in different position from 0 mmHg image) 
As a final note, it is recognized that there were datasets within this study 
in which significant differences were found, but where this significance was not 
obvious from the graphed data. These datasets illustrated a wide range of 
responses within the subject pool, but with each individual response following a 
similar trend. For example, the overall change in plasma volume between pre 
and post 28h NFL HDBR was less than 10%, but the standard deviation 
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exceeded 10%. Analysis of splanchnic impedance provides a second example 
where the difference between pre and post HDBR testing was not significant; 
however there was a significant LBNP effect. From the graphed data, this 
LBNP effect would not have been obvious due to the range of subjects' 







This study examined the hypotheses that 1) 28h HDBR would result in 
significant hypovolemia and cardiovascular deconditioning, and that 2) 
NASA‟s fluid loading protocol (15 ml/kg water with a 1g NaCl for every 125ml 
of water consumed) would restore normovolemia and prevent cardiovascular 
deconditioning resulting from 28h HDBR. Nine healthy young men were tested 
in 5 testing scenarios, with a progressive LBNP protocol performed before and 
after the scenario to measure the subjects‟ cardiovascular responses. Subjects 
were tested in two 28h HDBR conditions, without fluid loading (NFL) and with 
fluid loading (FL), as well as in three 4h control conditions to isolate the effects 
of circadian rhythm, HDBR, and fluid loading.   
This study found that the cardiovascular system had begun the process 
of deconditioning after exposure to only 28 hours of bed-rest. Affects of this 
short-term bed-rest exposure included significant hypovolemia, reductions in 
central venous pressure, and increased heart rate responses during orthostatic 
stress. Deconditioning did not include reductions in stroke volume or cardiac 
output, increased systemic vascular resistance, diminished cardiac performance 
or attenuation of the arterial and cardiopulmonary baroreflex, all of which have 
resulted from longer duration bed-rest exposure. There was also no evidence of 
venous or splanchnic pooling. From these results it can be concluded that 
hypovolemia is not a principal contributor to the cardiovascular deconditioning 
that accompanies bed-rest. Rather, prolonged inactivity in the supine position 
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may be responsible, with progressive cardiovascular deterioration occurring 
with longer durations of exposure. 
This study also indicated that, in contrast to the findings by Waters and 
colleagues, attempts to restore lost blood volume by ingestion of NASA‟s fluid 
loading protocol of salt and water was ineffective (Waters et al. 2005). In 
addition, subjects performed better during orthostatic challenge when the fluid 
loading protocol was not performed, as fluid loading caused symptoms of 
nausea and vomiting in 4 of the 9 subjects, and caused presyncopal symptoms 
during LBNP testing in one subject (subjects who did not complete the fluid 
loading protocol or vomited were not included in the overall statistical analysis 
studying the efficacy of fluid loading). Therefore other methods of fluid volume 
replacement should be explored if fluid volume replacement is to be pursued as 
a countermeasure to orthostatic hypotension following bed-rest and spaceflight. 
However, since this study provided evidence that hypovolemia is not the root 
cause of orthostatic hypotension following bed-rest, it is recommended that 
other methodologies, such as exercise, artificial gravity with a short-arm 
centrifuge, or application of lower body negative pressure (like the Russian 
Chibis suit), be pursued. 
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APPENDIX A: NUMERICAL SUMMARY OF DATA 
APPENDIX A1: 28H NFL HDBR DATA 
 Table A1-1: Mean Values of Blood Volume Variables Pre and Post 28h NFL HDBR                                  
(Mean ± Standard Error, † indicates HDBR effect (p<0.05)) 
 
Table A-2: Mean Values of Cardiovascular Pulmonary Baroreflex Responses during 
LBNP Testing Pre and Post 28h HDBR (Mean ± Standard Error, † HDBR Effect 
(p<0.05)) 
Variable 
28h NFL HDBR Pre Test 28h NFL HDBR Post Test 






NA NA NA NA 
0.43 ± 
0.01 






















































Table A-3: Mean Values of Arterial Baroreflex Responses during LBNP Testing Pre and 
Post 28h NFL HDBR (Mean ± Standard Error, † HDBR Effect (p<0.05))
Variable 
28h NFL HDBR Protocol Results 
Hour 0 (Pre) Hour 28 (Post) Difference 
Total Blood 
Volume (ml)† 
5641.6 ± 425.2 5246.5 ± 378.6 395.1 ± 46.6 
Plasma Volume 
(ml) † 
3431.9 ± 271.7 3036.8 ± 225.1 395.1 ± 46.6 
Hematocrit (%) † 39.61 ± 0.74 42.31 ± 0.63 -2.7 ± 0.11 
Weight (kg) † 73.7 ± 1.9 72.5 ± 1.9 -1.2 ± 0.5 
  28h NFL HDBR Pre 28h NFL HDBR Post 
Variable 0 mmHg -20 mmHg -40 mmHg 0 mmHg -20 mmHg -40 mmHg 






















































































Table A1-4: Mean Values of Cardiovascular Blood Pressure Responses during LBNP Testing Pre and Post 28h HDBR 
(*LBNP Effect, † HDBR Effect, ‡ LBNP-HDBR Interaction Effect (p<0.05)) 
 
 28h NFL HDBR Pre Test 28h NFL HDBR Post Test 
Variable 0 -10 -20 -30 -40 0 -10 -20 -30 -40 
MAP  
(mmHg) 












86.0 ± 3.6 84.1 ± 4.2 
SBP † 
(mmHg) 












116.9 ± 4.7 112.0 ± 5.3 
DBP 
(mmHg) 












70.4 ± 2.9 69.8 ± 3.4 
PP † 
(mmHg) 












46.5 ± 2.5 42.2 ± 2.4 
HR † ‡  
(beats/min)  












69.7 ± 3.6 79.3 ± 4.4 
R-R Interval † 
(s) 












0.89 ± 0.06 0.78 ± 0.05 
SV † ‡  
(ml/m2) 












36.3 ± 1.9 31.7 ± 1.7 
Q †  
(L/min/m2) 







2.41 ± 0.18 2.87 ± 0.22 
2.70 ± 
0.19 
2.60 ±  
0.16 











38.54 ± 4.63 
29.54 ± 
2.00 




35.67  ± 
2.19 
35.50 ± 2.84 
Arterial † Compliance  
([ml/m2]/mmHg) 
1.72  ±  0.25 1.22  ±  0.18 
CVP *†‡ 
(mmHg) 
8.7 ± 0.5 6.1 ± 0.4 4.2 ± 0.4 2.7 ± 0.5 1.8 ± 0.5 5.8 ± 0.5 3.6 ± 0.6 2.5 ± 0.5 1.8 ± 0.5 1.3 ± 0.5 
IVC diameter †  
(cm) 












0.92 ± 0.09 0.64 ± 0.06 
Venous Compliance 
(cm/mmHg) 
0.22 ± 0.03 0.25 ±0.03 
Portal  Diameter *†‡ 
(cm) 












0.52 ±0.04 0.47 ± 0.04 




















18.14 ± 1.49 
Splanchnic Impedance † (Ω/cm) 












1.56 ± 0.17 1.60 ± 0.17 
Ejection Fraction †  
(%) 
82.3 ± 1.7 NA NA NA 74.3 ± 1.9 79.5 ± 1.1 NA NA NA 72.2 ± 1.4 
Fractional Shortening † (%) 44.3 ± 1.7 NA NA NA 36.8 ± 1.6 41.2 ± 1.0 NA NA NA 34.9 ± 1.2 
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APPENDIX A2: 28H FL AND NFL POST DATA 
 
Table A.2-1: Mean Values of Blood Volume Variables Pre and Post 28h NFL and FL 
HDBR                    (Mean ± Standard Error) 
 
Table A2-2: Comparison Mean Values of Arterial Baroreflex Responses during LBNP 
Testing following 28h FL HDBR and 28h NFL HDBR (Mean ± Standard Error, † HDBR 
Effect (p<0.05)) 
 
Table A2-3: Comparison Mean Values of Cardiopulmonary Baroreflex Responses during 
LBNP Testing following 28h FL HDBR and 28h NFL HDBR (Mean ± Standard Error, † 
HDBR Effect (p<0.05)) 
 28h NFL HDBR Post Test 28h FL HDBR Post Test 






NA NA NA NA 
0.42 ± 
0.01 



















































28h NFL HBDR 28h FL HDBR 
Hour 0 Hour 28 Difference Hour 0  Hour 28  Difference 
Total Blood 






































-3.05 ± 0.68 
Weight 
(kg) 
75.0 ± 1.5 74.0 ± 1.5 1.0 ± 0.6 76.0 ± 1.6 74.9 ± 1.5 1.1 ± 0.3 
 28h NFL HDBR Post 28h FL HDBR Post 
Variable 0 mmHg -20 mmHg -40 mmHg 0 mmHg -20 mmHg -40 mmHg 






























































0.57 ± 0.03 0.45 ± 0.04 0.46 ± 0.03 0.57 ± 0.05 0.48 ± 0.06 0.41 ± 
0.05 
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Table A2-4: Mean Values of Cardiovascular Blood Pressure Responses during LBNP Testing following 28h FL HDBR and 28h NFL HDBR                                           




 28h NFL HDBR Pre Test 28h NFL HDBR Post Test 





















87.30 ± 5.92 









































72.92 ± 4.45 




















41.26 ± 3.88 




















71.01 ± 2.83 
R-R Interval † 
(s) 












0.96 ± 0.04 0.86 ± 0.03 




















31. 75 ± 2.22 
Q  †  
(L/min/m2) 
2.59 ± 0.12 











2.39 ± 0.16 2.23 ± 0.14 
TPR † 
(mmHg/{ml/ [min*m2]}) 














9.89 ± 0.91 10.71 ± 1.04 
Arterial  Compliance †  
([ml/m2]/mmHg) 
1.22 ± 0.18 1.48 ± 0.14 
CVP  *†‡ 
(mmHg) 







3.39 ± 0.40 3.20 ± 0.29 
1.99 ± 
0.27 
   
IVC diameter  †  
(cm) 







1.06 ± 0.17 0.74  ± 0.13 
0.53 ± 
0.06 
   
Venous Compliance (cm/mmHg) 0.27 ± 0.03 0.30 ± 0.06 
Portal  Diameter  *†‡ 
(cm) 












0.59 ± 0.06 0.49 ± 0.03 
Splanchnic Impedance  † (Ω/cm) 












1.85 ± 0.20 1.90 ± 0.20 









NA NA NA 71.08 ± 2.75 
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APPENDIX A3: CIRCADIAN RHYTHM CONTROL DATA 
Table A3-1: Mean Values of Cardiovascular Variables during LBNP Testing Pre and Post 
4h S NFL       (Mean ± Standard Error, † HDBR Effect (p<0.05)) 
 4h S NFL Pre 4h S NFL Post 


















NA NA NA NA 
Hematocrit (%) 40.19 NA NA NA NA 40.11 NA NA NA NA 









































































Table A3-2: Mean Values of Cardiovascular Variables during LBNP Testing Post 4h S 
NFL and Post 4h HDBR (Mean ± Standard Error, *LBNP Effect, † HDBR Effect, ‡ 
LBNP-HDBR Interaction Effect (p<0.05)) 
 4h S NFL Post 4h HDBR Post 
Variable 0 -10 -20 -30 -40 0 -10 -20 -30 -40 




NA NA NA NA 
-27.1 
± 58.0 
NA NA NA NA 




NA NA NA NA 
-27.1 
± 58.0 
NA NA NA NA 




NA NA NA NA 
0.57 ± 
0.54 

















































































APPENDIX A4: FLUID LOADING CONTROL DATA 
Table A4-1: Mean Values of Cardiovascular Variables during LBNP Testing Post 4-hour 
S NFL and Post 4-hour S FL (Mean ± Standard Error, † HDBR Effect (p<0.05)) 
 4-hour S NFL Post 4-hour S FL Post 
Variable 0 -10 -20 -30 -40 0 -10 -20 -30 -40 





NA NA NA NA 
-232.0 
± 98.6 






NA NA NA NA 
-232.0 
±  98.6 






NA NA NA NA 
1.82 ± 
0.80 
NA NA NA NA 














































































APPENDIX A5: HDBR CONTROL DATA 
Table A5-1: Mean Values of Cardiovascular Variables during LBNP Testing Post 4-hour 
S FL and Post 28h FL HDBR (Mean ± Standard Error, *LBNP Effect, † HDBR Effect, ‡ 
LBNP-HDBR Interaction Effect (p<0.05)) 
 4-hour S FL Post 28h FL HDBR Post 











NA NA NA NA 














NA NA NA NA 
2.88 ± 
0.53 
NA NA NA NA 







































































APPENDIX B: STATISTICS TABLES 
APPENDIX B1: 28H NFL HDBR STATISTICS SUMMARY 
 
Table B1-1: Results of 2-way Repeated Measures ANOVA (Pre/Post, LBNP) for Analysis 
of 28h NFL HDBR 
 P (*P<0.05) 
Variable Pre/Post Effect LBNP Effect Pre/Post vs. LBNP Effect 
Total Blood Volume 0.0002* NA NA 
Plasma Volume 0.0002* NA NA 
Hematocrit < 0.0001* NA NA 
Weight 0.0419* NA NA 
Heart Rate  0.2260 < 0.0001* 0.0124* 
R-R Interval 0.3154 < 0.0001* 0.0853 
Mean Arterial Pressure 0.9533 0.5039 0.4483 
Systolic Blood Pressure  0.8816 < 0.0001* 0.1236 
Diastolic Blood Pressure 0.9352 0.1662 0.6350 
Pulse Pressure  0.8584 <0.0001* 0.0307* 
Stroke Volume 0.2947 <0.0001* 0.0165* 
Cardiac Output 0.6732 0.0007* 0.7862 
Total Peripheral Resistance  0.8739 0.0014* 0.3582 
Arterial Compliance 0.2449 NA NA 
Venous Compliance 0.3100 NA NA 
Central Venous Pressure 0.0107* <0.0001* 0.0070* 
IVC Diameter 0.1944 <0.0001* 0.0600 
Portal Vein Diameter 0.0077* <0.0001* 0.0354* 
Portal Vein Blood Flow 0.0291* 0.2838 0.5117 
Splanchnic Impedance 0.3708 <0.0001* 0.3628 
Ejection Fraction 0.1948 0.0041* 0.9180 
Fractional Shortening 0.1664 0.0033* 0.4939 
MF Gain 0.8772 0.0008* 0.4911 
HF Gain 0.3735 0.0041* 0.9241 
MF Phase 0.4498 0.1232 0.6152 
HF Phase 0.0862 0.0010* 0.0614 
Brachial Blood Flow Velocity 0.1418 0.0021* 0.6222 
Brachial Blood Flow 0.0897 0.6487 0.9787 





Table B1-2: Preplanned Comparisons for Analysis of 28h NFL HDBR 
 P (*P<0.05) 
Variable Pre 0 mmHg vs. 
Post 0 mmHg 
Pre -40 mmHg vs. 
Post -40 mmHg 
Post 0 mmHg vs. 
Post -40 mmHg 
Mean Arterial Pressure 0.8748 0.6306 0.0412* 
Heart Rate 0.6400 0.0500* <0.0001* 
R-R Interval 0.6496 0.0479* <0.0001* 
Stroke Volume 0.2263 0.0855 <0.0001* 
Cardiac Output 0.4387 0.5700 0.0825 
Total Peripheral 
Resistance 
0.8480 0.6279 0.0583 
Arterial Compliance 0.7535 0.4539 0.4539 
Central Venous Pressure 0.0231* 0.0470* <0.0001* 
IVC Diameter 0.0470* 0.6132 <0.0001* 
Portal Vein Diameter 0.0669 0.0201* <0.0001* 
Portal Vein Blood Flow 0.0968 0.4050 0.2944 
Splanchnic Impedance 0.4274 0.3360 0.0105* 
Ejection Fraction 0.1877 0.2254 0.0014* 
Fractional Shortening 0.8663 0.9326 0.0015* 
Brachial Blood Flow 
Velocity 
0.1060 0.1326 0.0999 







APPENDIX B2: 28H FL AND NFL POST STATISTICS SUMMARY 
 
Table B2-1: Results of 2-way Repeated Measures ANOVA Comparing 28h FL HDBR and 
28h NFL HDBR Post Results (FL/NFL, LBNP) 
 P (*P < 0.05) 
Variable NFL/FL Effect LBNP Effect NFL/FL vs. LBNP Effect 
Total Blood Volume 0.2908 NA NA 
Plasma Volume 0.2190 NA NA 
Hematocrit 0.1848 NA NA 
Weight Change 0.9763 NA NA 
Heart Rate  0.3427 <0.0001* 0.2528 
R-R Interval 0.4257 <0.0001* 0.2235 
Mean Arterial Pressure 0.3545 0.0368* 0.3413 
Systolic Blood Pressure  0.3503 <0.0001 0.3890 
Diastolic Blood Pressure 0.4295 0.1485 0.4431 
Pulse Pressure  0.4046 <0.0001* 0.1982 
Stroke Volume 0.0667 <0.0001* <0.0087* 
Cardiac Output 0.3201 0.0002* 0.0125* 
Total Peripheral Resistance  0.4970 0.0004* 0.0824 
Arterial Compliance 0.1586 NA NA 
Central Venous Pressure 0.4425 <0.0001* 0.7071 
IVC diameter 0.4967 <0.0001* 0.7358 
Venous Compliance 0.8100 NA NA 
Portal Vein Diameter 0.2710 <0.0001* 0.5612 
Splanchnic Impedance 0.2252 <0.0001* 0.9590 
Ejection Fraction 0.7121 0.0139* 0.5184 
Fractional Shortening 0.7814 0.0100* 0.7882 
MF Gain 0.1277 0.0031* 0.5131 
HF Gain 0.9367 0.0009* 0.7680 
MF Phase 0.9762 0.3473 0.4524 
HF Phase 0.7323 0.0023 0.7936 
Brachial Blood Flow Velocity 0.9409 <0.0001* 0.2031 
Brachial Blood Flow 0.7388 0.4600 0.0828 






Table B2-2: Preplanned 1-way Repeated Measures ANOVA Comparisons between 28h FL 
HDBR Post and 28h NFL HDBR Post Tests 
 P (*P<0.05) 
Variable NFL Post 0 mmHg vs. FL 
Post 0 mmHg 
NFL Post -40 mmHg vs. FL 
Post -40 mmHg 
Heart Rate  0.6062 0.3328 
R-R Interval 0.6524 0.8600 
Mean Arterial Pressure 0.3004 0.4663 
Systolic Blood Pressure  0.3321 0.5327 
Diastolic Blood Pressure 0.3680 0.4352 
Pulse Pressure  0.5223 0.7470 
Stroke Volume 0.1874 0.3371 
Cardiac Output 0.1330 0.9805 
Total Peripheral Resistance 0.7662 0.2990 
Arterial Compliance 0.3281 0.4885 
Central Venous Pressure 0.5070 0.6734 
IVC Diameter 0.8468 0.2210 
Portal Vein Diameter 0.4611 0.8588 
Splanchnic Impedance 0.2329 0.2127 
Ejection Fraction 0.8097 0.6396 
Fractional Shortening 0.8356 0.7280 
Brachial Blood Flow Velocity 0.7360 0.6383 
Brachial Blood Flow 0.7748 0.4546 
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Table B2-3: Results of 2-way Repeated Measures ANOVA Comparing 28h NFL HDBR 
and 28h FL HDBR Pre Results (NFL/FL, LBNP) 
 P (*P < 0.05) 
Variable NFL/FL Effect LBNP Effect NFL/FL vs. LBNP Effect 
Total Blood Volume 0.8962 NA NA 
Plasma Volume 0.5764 NA NA 
Hematocrit 0.2993 NA NA 
Heart Rate  0.2211 <0.0001* 0.7142 
R-R Interval 0.1737 <0.0001* 0.6178 
Mean Arterial Pressure 0.3835 0.7721 0.6406 
Systolic Blood Pressure  0.2077 <0.0001* 0.3736 
Diastolic Blood Pressure 0.8763 0.0262* 0.8950 
Pulse Pressure  0.3682 <0.0001* 0.7231 
Stroke Volume 0.0510 <0.0001* 0.8700 
Cardiac Output 0.0567 0.0005* 0.9223 
Total Peripheral Resistance  0.1752 0.0005* 0.5386 
Arterial Compliance 0.0873 <0.0001* 0.5437 
Central Venous Pressure 0.1154 <0.0001* 0.7499 
IVC diameter 0.1663 <0.0001* 0.0771 
Venous Compliance 0.9812 NA NA 
Portal Vein Diameter 0.5097 <0.0001* 0.1615 
Splanchnic Impedance 0.3666 <0.0001* 0.9864 
Ejection Fraction 0.9455 0.0016* 0.2490 
Fractional Shortening 0.8700 0.0013* 0.1924 
MF Gain 0.1745 <0.0001* 0.9968 
HF Gain 0.1944 0.0023* 0.7702 
MF Phase 0.5789 0.1451 0.6829 
HF Phase 0.8660 0.0005* 0.6625 
Brachial Blood Flow Velocity 0.6939 0.0030* 0.4125 
Brachial Blood Flow 0.4562 0.0817 0.4977 
Brachial Diameter 0.6354 NA NA 
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APPENDIX B3: CIRCADIAN RHYTHM CONTROL STATISTICS 
SUMMARY 
 
Table B3-1: Results of 2-way Repeated Measures ANOVA (Pre/Post, LBNP) for Analysis 
of 4-hour S NFL 
 P (*P<0.05) 
Variable Pre/Post Effect LBNP Effect Pre/Post vs. LBNP Effect 
Total Blood Volume 0.8017  NA NA 
Plasma Volume 0.8017 NA NA 
Hematocrit 0.8705 NA NA 
Heart Rate  0.9217 <0.0001* 0.4765 
Central Venous Pressure 0.2004 <0.0001* 0.0933 
Portal Vein Diameter 0.3859 <0.0001* 0.9504 
 
 
Table B3-2: Results of 2-way Repeated Measures ANOVA comparing 4-hour S NFL Post 
and 4-hour HDBR Post Responses (4 S NFL Post/4 HDBR Post, LBNP) 
 P (*P<0.05) 
Variable 4 S NFL Post/4 
HDBR Post Effect 
LBNP Effect SNFL/HDBR vs. 
LBNP Effect 
Δ Total Blood Volume 0.5568 NA NA 
Δ  Plasma Volume 0.9195 NA NA 
Hematocrit 0.4552 NA NA 
Heart Rate  0.0009* <0.0001* 0.0100*
 
Central Venous Pressure 0.0150* <0.0001* 0.9102 
Portal Vein Diameter 0.0178* <0.0001* 0.0462* 
 
 
Table B3-3: Results of 2-way Repeated Measures ANOVA comparing 4-hour S NFL Pre 
and 4-hour HDBR Pre Responses (4 S NFL Pre/4 HDBR Pre, LBNP) 
 P (*P<0.05) 
Variable 4 S NFL Pre/4 HDBR 
Pre Effect 
LBNP Effect SNFL/HDBR vs. 
LBNP Effect 
Heart Rate  0.1342 <0.0001* 0.1543 
Central Venous Pressure 0.1328 <0.0001* 0.2578 
Portal Vein Diameter 0.0963 <0.0001* 0.4931 
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APPENDIX B4: FLUID LOADING CONTROL STATISTICS SUMMARY 
 
Table B4-1: Results of 2-way Repeated Measures ANOVA comparing 4-hour S NFL Post 
and 4-hour S FL Post Responses (4 S NFL Post/4 S FL Post, LBNP) 
 P (*P<0.05) 
Variable 4 S NFL Post/4 S FL 
Post Effect 
LBNP Effect S NFL/S FL vs. 
LBNP Effect 
Δ  Total Blood Volume 0.8017  NA NA 
Δ  Plasma Volume 0.8017 NA NA 
Δ  Hematocrit 0.8705 NA NA 
Heart Rate  0.2063 <0.0001* 0.1752 
Central Venous Pressure 0.7658 <0.0001* 0.3072 
Portal Vein Diameter 0.5706 <0.0001* 0.8525 
 
 
Table B4-2: Results of 2-way Repeated Measures ANOVA comparing 4-hour S NFL Pre 
and 4-hour S FL Pre Responses (4 S NFL Pre/4 S FL Pre, LBNP) 
 P (*P<0.05) 
Variable 4 S NFL Pre/4 S FL 
Pre Effect 
LBNP Effect S NFL/S FL vs. 
LBNP Effect 
Heart Rate  0.3227 <0.0001* 0.1930 
Central Venous Pressure 0.0793 <0.0001* 0.4784 





APPENDIX B5: HDBR CONTROL STATISTICS SUMMARY 
 
Table B5-1: Results of 2-way Repeated Measures ANOVA comparing 4-hour S FL Post 
and 28h FL HDBR Post Responses (4h S FL Post /28h FL HDBR Post, LBNP) 
 P (*P<0.05) 
Variable 4h S FL Post/28h FL 
Post HDBR Effect 
LBNP Effect Interaction Effect 
Δ Total Blood Volume 0.0022 NA NA 
Δ  Plasma Volume 0.0022 NA NA 
Δ  Hematocrit 0.0013 NA NA 
Heart Rate  0.1817 <0.0001* 0.0101* 
Central Venous Pressure 0.6495 <0.0001* 0.0353* 
Portal Vein Diameter 0.3725 <0.0001* 0.5215 
 
 
Table B5-2: Results of 2-way Repeated Measures ANOVA comparing 4-hour S FL Pre 
and 28h FL HDBR Pre Responses (4h S FL Pre /28h FL HDBR Pre, LBNP) 
 P (*P<0.05) 
Variable 4h S FL Pre/28h FL 
HDBR Pre Effect 
LBNP Effect Interaction Effect 
Heart Rate  0.9520 <0.0001* 0.8018 
Central Venous Pressure 0.2911 <0.0001* 0.9811 
Portal Vein Diameter 0.2185 <0.0001* 0.7289 
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APPENDIX C: SAMPLE SIZES 
 
Table C-1: Sample Sizes for 28h HDBR Pre versus Post Comparison Data 
 28h NFL HDBR Pre Test 28h NFL HDBR Post Test 
 0 -10 -20 -30 -40 0 -10 -20 -30 -40 
Total Blood Volume 8 8 
Plasma Volume 8 8 
Hematocrit 9 9 
Weight 9 9 
Heart Rate  9 9 9 9 9 9 9 9 9 9 
R-R Interval 9 9 9 9 9 9 9 9 9 9 
Mean Arterial Pressure 9 9 9 9 9 9 9 9 9 9 
Systolic Blood Pressure  9 9 9 9 9 9 9 9 9 9 
Diastolic Blood Pressure 9 9 9 9 9 9 9 9 9 9 
Pulse Pressure  9 9 9 9 9 9 9 9 9 9 
Stroke Volume 9 9 9 9 9 9 9 9 9 9 
Cardiac Output 9 9 9 9 9 9 9 9 9 9 
Total Peripheral Resistance  8 8 8 8 8 8 8 8 8 8 
Arterial Compliance 8 8 
Central Venous Pressure 8 8 8 8 8 8 8 8 8 8 
IVC Diameter 9 9 9 9 9 9 9 9 9 9 
Venous Compliance 6 6 
Portal Vein Diameter 9 9 9 9 9 9 9 9 9 9 
Portal Flow 9 9 9 9 9 9 9 9 9 9 
Splanchnic Impedance 8 8 8 8 8 8 8 8 8 8 
Ejection Fraction 8 NA NA NA 8 8 NA NA NA 7 
Fractional Shortening 7 NA NA NA 7 7 NA NA NA 7 
MF Gain 7 NA 7 NA 7 7 NA 7 NA 7 
HF Gain 7 NA 7 NA 7 7 NA 7 NA 7 
MF Phase 7 NA 7 NA 7 7 NA 7 NA 7 
MF Phase 7 NA 7 NA 7 7 NA 7 NA 7 
MF Coherence 7 NA 7 NA 7 7 NA 7 NA 7 
HF Coherence 7 NA 7 NA 7 7 NA 7 NA 7 
Brachial Diameter 9 9 
Brachial Blood Flow Velocity 8 8 8 8 8 8 8 8 8 8 
Brachial Blood Flow 8 8 8 8 8 8 8 8 8 8 
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Table C-2: Sample Sizes for 28h FL HDBR Post verses 28h NFL HDBR Post Comparison Data 
 28h NFL HDBR Post Test 28h FL HDBR Post Test 
 0 -10 -20 -30 -40 0 -10 -20 -30 -40 
Total Blood Volume  6 6 6 6 6 6 6 6 6 6 
Plasma Volume 6 6 6 6 6 6 6 6 6 6 
Hematocrit 7 7 7 7 7 7 7 7 7 7 
Weight 7 7 7 7 7 7 7 7 7 7 
Heart Rate  7 7 7 7 7 7 7 7 7 7 
R-R Interval 7 7 7 7 7 7 7 7 7 7 
Mean Arterial Pressure 7 7 7 7 7 7 7 7 7 7 
Systolic Blood Pressure  7 7 7 7 7 7 7 7 7 7 
Diastolic Blood Pressure 7 7 7 7 7 7 7 7 7 7 
Pulse Pressure  7 7 7 7 7 7 7 7 7 7 
Stroke Volume 7 7 7 7 7 7 7 7 7 7 
Cardiac Output 7 7 7 7 7 7 7 7 7 7 
Total Peripheral Resistance  5 5 5 5 5 5 5 5 5 5 
Arterial Compliance 8 8 
Central Venous Pressure 5 5 5 5 5 5 5 5 5 5 
IVC Diameter 7 7 7 7 7 7 7 7 7 7 
Venous Compliance 6 6 
Portal Vein Diameter 7 7 7 7 7 7 7 7 7 7 
Portal Flow 7 7 7 7 7 7 7 7 7 7 
Splanchnic Impedance 6 6 6 6 6 6 6 6 6 6 
Ejection Fraction 6 6 6 6 6 6 6 6 6 6 
Fractional Shortening 6 6 6 6 6 6 6 6 6 6 
MF Gain 5 5 5 5 5 5 5 5 5 5 
HF Gain 5 5 5 5 5 5 5 5 5 5 
MF Phase 5 5 5 5 5 5 5 5 5 5 
HF Phase 5 5 5 5 5 5 5 5 5 5 
MF Coherence 5 NA 5 NA 5 5 NA 5 NA 5 
HF Coherence 5 NA 5 NA 5 5 NA 5 NA 5 
Brachial Diameter 7 NA NA NA NA 7 NA NA NA NA 
Brachial Blood Flow Velocity 5 5 5 5 5 5 5 5 5 5 
Brachial Blood Flow 5 5 5 5 5 5 5 5 5 5 
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APPENDIX D: AORTIC DOPPLER ULTRASOUND DATA 
 
LB N P  (m m H g)
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Figure D-1: Stroke Volume Response during Pre and Post 28h NFL HDBR 
Testing (measured by Doppler Ultrasound) 
LB N P  (m m H g)
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Figure D-2: Cardiac Output during Pre and Post 28h NFL HDBR Testing 
(measured by Doppler Ultrasound) 
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Figure D-3: Total Peripheral Resistance Response during Pre and Post 28h 
NFL HDBR Testing (measured by Doppler Ultrasound) 
LB N P  (m m H g)
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Figure D-4: Arterial Compliance Response during Pre and Post 28h NFL 
HDBR Testing (measured by Doppler Ultrasound) 
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APPENDIX E: PORTAL VEIN BLOOD FLOW DATA 
LB N P  (m m H g)
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Figure E-1: Portal Vein Blood Flow Response during Pre and Post 28h 
NFL HDBR Testing 
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Figure E-2: Portal Vein Blood Flow Response following 28h NFL HDBR 
and 28h FL HDBR Response 
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APPENDIX F: CARDIOPULMONARY BAROREFLEX DATA 
 C ard iopu lm ona ry  B a ro re flex  R esponse  fo llow ing  28  H D B R
LB N P  (m m H g)































Figure F-1: Cardiopulmonary Baroreflex Response (Forearm Vascular 
Resistance vs. Orthostatic Stress) during Pre and Post 28h NFL HDBR 
Testing 
LB N P  (m m H g)
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Figure F-2: Cardiopulmonary Baroreflex Response (Forearm Vascular 
Resistance vs. Orthostatic Stress) following 28h NFL HDBR and 28h FL 
HDBR Response 
